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Abstract  
 Pathologies concomitant with old age such as arthritis, osteoporosis, and obesity 
diminish the quality of life for society’s elderly. Recent advances in regenerative 
medicine have revealed that an abundant and readily available source of adult 
mesenchymal stem cells (MSCs), resides within adipose tissue. Previous research has 
demonstrated that MSCs can differentiate into multiple specialized cell types and may 
thus be capable of ameliorating symptoms of many age-associated diseases. However, 
several unique challenges currently limit the usefulness of adipose-derived MSCs in 
regenerative therapies. In this thesis I assessed novel ways of isolating and differentiating 
adipose-derived MSCs into desired cell types. Specifically, I assessed the capacity of a 
non-enzymatic sonication based method to the collagenase digestion based method of 
isolating MSCs from human adipose. Sonication yielded fewer total cells than 
collagenase. However, alizarin red staining revealed that cells obtained using sonication 
possessed a stronger osteogenic capacity than those obtained using collagenase. 
Additionally, oil red o staining showed that both methods produced cells capable of 
adipogenesis. Yet, alcian blue staining demonstrated that sonication was unable to yield 
cells capable of chondrogenisis. Lastly, rat adipose-derived stromal cells were cultured in 
medium containing stimulators of UCP1 expression in order to induce a brite cell 
phenotype. Following a 9 day treatment period, cultures displayed characteristic traits of 
brite cells such as increased intra-cellular lipid accumulation and increased mitochondrial 
content. However, when exposed to acute norepinephrine treatment, stromal cells did not 
display an increased rate of respiration. Furthermore, western blot analysis revealed that 
these cells did not express UCP1, suggesting that the differentiation treatment likely only 
 
 
induced a partial differentiation response. Overall, the above work provides valuable 
insight into addressing challenges currently limiting the usefulness of adipose-derived 
MSCs in regenerative therapies. Future works should assess the differentiation capacity 
of stromal cultures depleted of non-MSC cells and stromal cells obtained using sonication 
in medium containing additional inducers of differentiation. Moreover, future efforts 
based on the brite cell differentiation method used here should assess whether extending 
treatment induction/differentiation periods is capable of producing brite cell phenotype. 
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Chapter 1: Literature Review 
1.1 Introduction 
Over the past several hundred years, average human life expectancy throughout 
the developed world has increased (1). However, greater longevity has also 
heightened awareness of the impact of age-related pathologies on the quality of life 
for society’s elderly. Pathologies related to reduced bone mass through osteoporosis 
and loss of cartilage tissue with concomitant arthritis both increase with age. 
Moreover, the incidence of obesity and obesity-associated conditions such as glucose 
intolerance, type II diabetes mellitus, and hypertension also correlate with age. Such 
pathologies diminish quality of life by eliciting physical discomfort and limiting 
mobility (2-4). Considering this, the medical community has paid significant attention 
to the potential of stem cell based regenerative therapies to combat pathologies 
experienced in old age.  
Stem cells are undifferentiated cells that divide asymmetrically into one cell that 
retains its undifferentiated character, and a second that can undergo one or more paths 
of lineage-specific differentiation (5). Research efforts towards developing 
regenerative therapies have revealed that populations of stem cells residing in adult 
tissues (e.g. bone marrow, adipose, tendon, and ligament), known as mesenchymal 
stem cells (MSCs), possess the capacity to differentiate along the osteogenic and 
chondrogenic lineages becoming bone cells (osteoblasts) and cartilage cells 
(chondroblasts), respectively (6). Moreover, MSCs also possess the ability to 
differentiate into brown fat-like cells (brite cells) which contain intracellular 
machinery capable of dissipating energy through mitochondrial proton leak (7, 8). 
Previous investigations have demonstrated that implantation of MSCs into bone or 
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cartilage defects enhances the repair of these tissues, while increased brown fat 
activity can elicit weight loss in obese animal models (9-13). Thus, MSCs possess the 
ability to differentiate into specialized cells capable of ameliorating multiple 
pathologies associated with advanced age.  
For experimental and therapeutic applications, MSCs have traditionally been 
isolated from bone marrow. However, obtaining MSCs from marrow is invasive and 
painful. Conversely, adipose deposits contain MSCs, are ubiquitous, and are easily 
accessible in large quantities via liposuction aspiration. Moreover, adipose tissue is 
routinely extracted from adults undergoing liposuction surgery, and subsequently 
discarded (14, 15). Considering the above, the development of novel methods for 
isolating MSCs from adipose tissue and differentiating them into desired lineages is 
an import step towards developing less-invasive stem cell based therapies.    
It is the aim of this literature review to: 1) Provide information regarding the 
isolation of MSCs from tissues and the subsequent differentiation of these MSCs into 
specific cell types, 2) describe the advantages of adipose derived MSCs over those 
obtained from other tissues, and 3) introduce literature supporting the usefulness of 
MSC based therapy in conferring relief from age-related diseases. 
1.2 MSCs from bone marrow 
During embryogenesis MSCs reside within the middle embryonic layer known as 
the mesoderm. The term mesenchyme is derived from the Greek meaning “middle” 
(meso) “infusion” and refers to the ability of MSCs within the mesoderm to spread 
and migrate early in development giving rise to all the body’s mesenchymal tissues: 
cartilage, tendon, bone, ligament, marrow, and adipose, dermis, muscle, and several 
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connective tissues (16). Evidence that the stroma (supportive structural framework) of 
adult tissue contains populations of stem cells capable of forming mesenchymal tissue 
originally arose from the findings of A.J. Friedenstein. By repeated pipetting, 
Friedenstien et al. 1970 obtained cell suspensions from guinea pig bone marrow, 
spleen, and bladder epithelium. The authors observed that following 9-12 days in 
culture, isolated cells developed into discrete fibroblast-like colonies. These cells 
were subsequently harvested and placed into heterotopically implanted diffusion 
chambers (vessels which contain cells and allow for diffusion of nutrients while 
barring cell migration into and out of the chamber).  Using histological dyes to detect 
the presence of alkaline phosphatase, a marker of bone formation, the authors 
observed that the marrow derived cells formed bone tissue, while spleen and bladder 
derived cells did not (17), suggesting that stromal cells within adult marrow possess 
the ability to differentiate into a mesenchymal tissue. 
In later decades, other works extended these observations and demonstrated that 
the cells identified by Friedenstein could spontaneously transform into other 
mesenchymal tissues including cartilage and adipose (18). The first direct evidence 
that bone marrow stroma contained multipotent stem cells was provided by Pittenger 
et al. 1999 (19).  In order to obtain a purified population of marrow stromal cells, 
Pittinger et al isolated cells based on surface antigen expression using fluorescence 
activated cell sorting (FACS). They then clonally expanded these cells in order to 
obtain identical cultures derived from the same parental cell. These colonies were 
then cultured on separate plates and provided chemical inducers of adipogenic, 
osteogenic, or chondrogenic differentiation. Using histological stains to detect 
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differentiation, the authors observed that cultures derived from the same marrow cell 
could be differentiated into adipose, bone, and cartilage, thus demonstrating that 
marrow stroma contains multipotent stem cells. 
1.3 MSCs from adipose 
Following the discovery of MSCs in bone marrow, their potential use in 
regenerative medicine has been intensely pursued. Procedures used to obtain MSCs from 
marrow are painful and require general or spinal anesthesia.  They yield relatively low 
numbers of stem cells (approximately 1 MSC per 105 tissue culture plastic adherent cells) 
(20). From a practical standpoint, low stem cell numbers necessitate an in vitro expansion 
step to obtain a suitable number of cells for clinical use. Such expansion is time 
consuming, expensive, and risks cell contamination and loss. Stem cells capable of 
differentiation into mesenchymal tissues have been isolated from the stroma of serval 
connective tissues of multiple species including, birds, mice, rats, rabbits, and humans 
(19, 21-26). Unlike bone marrow, adipose tissue can be obtained in large quantities 
through liposuction surgery (20). Yet, like bone marrow, adipose is of mesenchymal 
origin (27). Considering this, Zuk et al. 2001 investigated whether human adipose could 
be an alternative source of MSCs (28).  The authors obtained human adipose from 
liposuction aspirate and used collagenase to liberate stromal cells from the extracellular 
matrix. The isolated adipose stromal cells were cultured with inducers of adipogenic, 
osteogenic, and chondrogenic differentiation. Zuk et al. observed that adipose stromal 
cells were capable of developing intracellular lipid stores, alkaline phosphatase 
expression, or proteoglycan expression, markers indicative of adipose, bone, and cartilage 
tissues, respectively. In order to determine if the isolated adipose stromal cells were 
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indeed stem cells, Zuk et al. 2002 examined surface antigen expression and 
differentiation capacity of clonogenic cultures (29).  Using FACS, the authors observed 
that the clonogenic cells expressed similar surface antigens (see below for explanation of 
surface antigens) to marrow MSCs. Moreover, the authors observed that the clonal cells 
were capable of differentiating into adipocytes, osteoblasts, and, chondrocytes, 
demonstrating that adipose tissue contains a population of MSCs. 
 In order to determine if adipose is a comparable source of MSCs to bone marrow, 
recent investigations have compared yields and differentiation capacities of cells isolated 
from each tissue. For example, Ugarte et al. 2003 found no significant difference in the 
number of culture adherent cells per gram of stromal cells obtained from human marrow 
or adipose tissue (30). Yet more than double the average mass of adipose tissue (17g) 
could easily be isolated from each patient compared to bone marrow (7g). The authors 
also cultured isolated cells in various differentiation media. Ugarte et al. found no 
difference in the number of cells that developed lipid droplets (adipogenic cells), or the 
alkaline phosphate activity of osteogenic cells. However, when induced to differentiate 
into cartilage, adipose derived cells stained positive for chondrogenesis while marrow 
derived cells did not. Using similar methods, several other investigations have compared 
the ability of marrow and adipose cells to differentiate along these lineages and have 
demonstrated that cells from either tissue possess an equal capacity to become adipose, 
bone, and cartilage (31, 32). Taken together, the above evidence demonstrates that 
compared to marrow, a high number of MSCs capable of multi-lineage differentiation 
can be obtained from adipose.  
1.4  Heterogeneity of adipose stromal cells 
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The stroma of adipose is composed of several different cell types, of which MSCs 
are the minority (>1%) (33). The main cellular component of adipose is mature 
adipocytes. Other major cell types include endothelial cells which comprise blood 
vessels, fibroblasts that produce extracellular matrix, and cells of hematopoietic origin 
including granulocytes, monocytes, and lymphocytes (34). During the isolation of MSCs 
from adipose stroma a heterogeneous population of cells will be obtained (mature 
adipocytes are easily removable as a supernatant due to their fat content and therefore 
low sedimentation coefficient). Because of this plurality of cell types, the cell population 
established from adipose tissue may not display a robust differentiation response when 
analyzed using histochemical techniques, compared to a culture with a higher proportion 
of stem cells.  With this in mind, various investigators have exploited the expression of 
specific cell surface antigens (markers) to distinguish and separate MSCs from non-MSC 
stromal cells (33). According to the International Federation for Adipose Therapeutics 
and Sciences (IFATS) adipose-derived MSCs should express CD34, CD13, CD73, CD90, 
and CD105 and be negative for CD45, CD235a, and CD31 (33). In practice, however, the 
surface antigen profile attributed to adipose derived-MSCs is highly variable between 
research groups (see Table 1).  In contrast, many non-MSC stromal cells express unique 
surface antigens that MSCs lack, and these can also be used for cell identification and 
separation.  Described below are markers expressed by endothelial cell, fibroblasts, and 
cells of hematopeoitc origin, which together comprise the majority of adipose stromal 
cells. 
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Table 1.1 : Adipose derived-MSC marker profiles   
 
Markers profile Reference 
CD 29, CD 44, CD 45, CD 90, MHC I, MHC II 35  
CD 29, CD 44, CD 45 36 
CD 29, CD 45, CD 54, CD 90, CD 106 37 
CD 34, CD 44, CD 45, CD 90 38 
CD 34, CD 45, CD 29, CD 44, CD 90 39 
CD 105, CD 29, CD 45, CD 34 40 
CD 11b, CD 45, CD 90 41 
CD 34, Stro-1 42 
CD 34, CD 44, CD 29, CD90 43 
CD 29, CD 90, CD 54, CD 45, CD 11b, CD 
106, MHC I, MHC II 
44 
CD 34, CD 45, CD 44, CD 90 45  
 
CD54 (Intracellular adhesion molecule-1, ICAM-1) is a cell surface glycoprotein 
expressed on endothelial cells, fibroblasts, lymphocytes and monocytes, but absent on 
MSCs. CD54 belongs to the ICAM family of proteins. ICAMs possess roles in the 
development of the nervous system, in immune and inflammatory responses. ICAM-1 
specifically participates in the trafficking of inflammatory cells, in adhesion of antigen-
presenting cells to T-lymphocytes during antigen presentation, and in microbial 
pathogenesis (46). Stromal CD54 expression varies among studies (47). Blasi et al. found 
that 19.6% +/- 9.4 of stromal cells express CD54 (48). Similarly, Zhao et al. found that 
11.0% +/- 0.7 of adipose tissue cells express CD54 (49). Conversely, other groups have 
reported that adipose stromal cell populations contain ~40% to more than 80% CD54 
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positive cells (50, 51). Recently, Zhao et al. proposed that CD54 may be used as a marker 
to distinguish adipose MSCs from local fibroblasts (49). Using magnet activated cell 
sorting, Zhou et al. separated CD54 positive cells from stromal cells. The authors found 
that the adipogenic and osteogenic differentiation capacity of the CD54 negative 
population was enhanced compared to the cultures containing CD54 positive cells.  
CD45 (also called common leukocyte antigen, CLA) is a cell surface protein 
tyrosine phosphatase that controls lymphocyte development, signals emanating from 
integrin and cytokine receptors, and is expressed by all hematopoietic lineage cells (T 
lymphocytes, B lymphocytes, monocytes, granulocytes etc.) except for erythrocytes and 
platelets (52).  Importantly, hematopoietic stem cells (HSCs) and mesenchymal stem 
cells (MSCs) do not express CD45. IFATS recommends using CD45 to distinguish 
MSCs from specialized immune cells (33). Adipose stromal cell populations from either 
rat or human tissue are negative or possess low expression of CD45 positive cells (53-
58). 
CD31 (Platelet endothelial cell adhesion molecule-1, PECAM-1) is a cell surface 
adhesion protein expressed on most leukocytes, platelets, and on endothelial cells. CD31 
plays an important role in regulating the attachment of leukocytes to endothelial cells on 
vessel walls and the migration of leukocytes through the vessel wall into tissues. In 
regards to endothelial cells, concentrated stores of CD31 have been observed in surface 
vascular membrane invaginations at endothelial cell junctions (59). ISCT/IFATS 
recommends the use of CD31 for negative selection against endothelial cells in adipose 
SVF populations (33). Analyses of human adipose SVF cell populations show that CD31 
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positive cells are present in adipose SVF. For example Gimble et al. 2006 found that 
~20% of human adipose SVF express CD31 (60).  
Taken together, the above evidence suggests that adipose stromal culture 
populations may be enriched for MSCs through the selective removal of cells expressing 
CD 54, CD45, and CD31. This strategy was therefore implemented to increase the 
proportion of MSCs in cell cultures established from rat adipose tissue (see below). 
1.5 MSC Differentiation 
In addition to their surface antigen profile, MSCs are defined by the ability to 
undergo adipogenic, osteogenic, and chondrogenic lineage specific differentiation 
(33). Moreover, adipose MSCs can give rise to brite cells (7, 8). In order to 
differentiate into these distinct cell types, MSCs must express unique sets of genes 
which ultimately produce functional proteins whose activities support the specialized 
functions of the differentiated cell. To study the process of MSC differentiation, 
various investigators have developed panels of molecular inducers that stimulate 
MSCs to undergo lineage specific differentiation in vitro.  With these concepts in 
mind, reviewed below is information regarding methods for differentiating MSCs into 
bone, cartilage, fat, and brite cells. 
1.5.1 Osteogenesis 
 The extracellular matrix of bone tissue contains mineral salt commonly called 
osteoid, which is a crystalline complex of calcium and phosphate also known as 
hydroxyapatite [Ca10(PO4)6(OH)2] (62).  Inorganic hydroxyapatite crystals comprise 
~69% of the material found in bone tissue.  These crystals are found deposited along 
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collagen fibrils within the extracellular matrix (62). Collagen type I protein is the second 
most abundant constituent of bone, accounting for most of the remaining 31% (63). Non-
collagen proteins such as proteoglycans, sialoproteins, gamma-carboxyglutamic acid-
containing proteins, and 2HS-glycoproteins are minor components (62).  
 The process of bone formation through osteogenesis is facilitated by 
flat/rectangular support cells known as osteoblasts which are derived from MSCs of the 
bone marrow stroma. As osteoblasts differentiate they gain the ability to secrete the 
constituents of osteoid into the extracellular matrix. Subsequently, osteoblasts become 
trapped in the bone matrix and give rise to osteocytes, which gradually stop secreting 
matrix (62).  
The differentiation of MSCs into osteoblasts is governed by several transcription 
factors that control the expression of osteogenic specific genes, one of the most well 
characterized being Run2x. Run2x is expressed in MSCs early in skeletal development 
and throughout osteoblast differentiation (64). Overexpression of Run2x alone can induce 
osteogenesis in vitro and in vivo, increasing osteoid production and accelerating healing 
of bone defects, respectively (65). Takahashi et al. 2011 demonstrated that the 
overexpression of Run2x in the pre-adipocyte cell line, 3T3-E1, caused an increase in 
osteogenic genes (67). Conversely, Run2x-null mice display a complete absence of 
osteogenesis due to a differentiation arrest of osteoblasts (66).  
In vitro differentiation of MSCs into osteoid secreting osteoblasts can be achieved 
through the use of a multi-week treatment strategy with dexamethasone, β-
glycerophosphate, and ascorbic acid (68). Dexamethasone is a synthetic corticosteroid 
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not found naturally in vivo that imitates the actions of glucocorticoids (69). As early as 
1985, Tenebaum and Heersche demonstrated that dexamethasone is capable of inducing 
osteogenesis in chick periosteum cells in vivo (70). Since this time, investigations have 
revealed that dexamethasone interacts simultaneously with several signalling cascades 
inducing Run2x transcription. Hamidouche et al. 2008 demonstrated that the FHL2 (four 
and a half LIM domains 2) protein  mediates dexamethasone induced osteogenesis by 
activating the WNT/ β-catenin signaling which in turn activates the transcription of 
Run2x (71). Additionally, Phillips et al. 2006 observed that dexamethasone increase 
mitogen-activated kinase (MAPK) phosphatase (MKP-1) which in turn facilitates the 
dephosphorylation of a serine residue leading to enhanced Run2x activity (72).  
In addition to dexamethasone, ascorbic acid and β-glycerophosphate are required 
for in vitro osteogenesis. Ascorbic acid stimulates osteogenesis by aiding in the 
production of collagen type I. In order to do this, ascorbic acid acts as a co-factor for 
enzymes that hydroxylate proline residues of the collagen precursor, pro-collagen. In the 
absence of ascorbic acid, proline cannot be hydroxylated and collagen chains are not able 
to form a proper helical structure (73). In addition to being an essential structural 
component of osteoid it is further hypothesized that the presence of collagen facilitates 
enhanced Run2x expression through the activation of cell surface intergrin receptors (68). 
Furthermore, β-glycerophosphate plays an important role in osteogenesis, however the 
mechanism through which β-glycerophosphate acts is unclear. It is believed that β-
glycerophosphate acts as a source of organic phosphates that aid in extracellular matrix 
mineralization. Moreover β-glycerophosphate may also aid in the ability of alkaline 
phosphatase to hydrolyze organic phosphate into inorganic phosphate. This free 
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phosphate may provide the chemical potential for promoting mineral deposition on the 
surface of tissue culture plastic by osteoblasts (69).  
1.5.2 Chondrogenesis 
 Cartilaginous tissue is composed of a dense extracellular matrix with a sparse 
population of specialized cells known as chondrocytes (74). The extracellular matrix is 
the principle functional component of cartilage and mainly comprises water, collagen, 
and proteoglycans. Water is the most abundant component of cartilage, contributing up to 
~80% of its wet weight. Collagen is the most abundant macromolecule in the 
extracellular matrix, and makes up ~60% of the dry weight of cartilage. Collagen proteins 
contain a region consisting of 3 polypeptide chains wound into a triple helix. This 
structure provides cartilage with important shear and tensile properties, which help to 
stabilize the matrix. Type II collagen represents 90%-95% of the collagen in the matrix. It 
forms fibrils and fibers that intertwine aggregates of proteoglycans. Collagen types I, IV, 
V, VI, IX, and XI are also present, but in lesser amounts.  Proteoglycans represent the 
second most abundant group of macromolecules in the extracellular matrix and account 
for ~10 to 15% of the wet weight. Proteoglycans are heavily glycosylated protein 
monomers consisting of a protein core with one or more linear glycosaminoglycan chains 
covalently attached. Cartilage contains a variety of proteoglycans including aggrecan, 
decorin, biglycan, and fibromodulin. The interaction between proteoglycans and type II 
collagen aids in providing compressive and tensile strength to the tissue (74). 
 Chondrocytes are the resident cell type in cartilage and are responsible for the 
production of the extracellular matrix during development through a process known as 
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chondrogenesis. At the onset of development of the skeletal system, mesenchymal stem 
cells commit to chondrogenesis and differentiate into pre-chondrocytes and then 
chondroblasts. These cells form the rudimentary basis for skeletal structures. In the center 
of future long bones, the cells become tightly packed and undergo stages of proliferation, 
hypertrophy, maturation into chondrocytes, and then apoptosis.  Subsequently, bone-
forming cells invade the lacunae of apoptotic chondrocytes and establish ossification 
centers, replacing the areas formerly occupied by cartilage with bone. This process 
continues until the bones have elongated to a mature length (75). At the either end of 
developing long bones, articular joints form where mesenchymal stem cells located in 
presumptive joint areas differentiate into pre-chondrocytes and then undergo apoptosis to 
create joint cavities. Chondroblasts that line the cavities develop into cartilage producing 
chondrocytes, forming the cartilaginous lining of long bones (76). 
 In vivo, the commitment of MSCs to the chondrogenic lineage is initiated by the 
sonic hedgehog signaling pathway through the increased expression of bone 
morphogenetic proteins (BMPs), which direct MSCs towards chondrogenesis (76). Early 
chondrogenesis is also characterized by high expression levels of the transcription factor 
Sox9 which is a key transcription factor for chondrocyte development (77). For example, 
the inactivation of Sox9 in mouse embryos specifically in early limb bud MSCs prior to 
cartilage formation, results in a complete absence of cartilage in the appendages (78). 
Sox9 is initially responsible for repressing the expression of the osteogenic factor Run2x. 
Through repression of Run2x, Sox9 ensures chondrogenic commitment of MSCs over 
osteogenic development (79). Two other Sox family members, L-Sox5 and Sox6 are 
required for Sox9-mediated transformation of cells into chondroblasts (80, 81). 
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Moreover, Sox9 in concert with L-Sox5 and Sox6, maintain the chondrocyte phenotype 
in developed cartilage by activating the expression of several cartilage specific genes for 
collagen types II, IX, and XI and the proteoglycan, aggrecan (82, 83).  
 In order to induce chondrogenesis of MSCs in vitro, culture medium is 
supplemented with specific growth factors, hormones, and synthetic compounds. 
Transforming growth factor β (TGFβ) peptides are common supplements. These peptides 
are secreted as one of four isoforms and act as signaling molecules by binding 
heteromeric cell surface serine/threonine kinase receptor complexes consisting of dimeric 
type I and type II receptors. Binding of the ligand to a type II receptor activates the type I 
receptor which results in the phosphorylation of cytoplasmic Smad molecules. 
Subsequently, activated Smads translocate to the nucleus and act as transcriptional co-
factors and directly influence gene transcription (84). TGFβ is included in MSC 
chondrogenic mediums in order to induce the secretion of cartilaginous ECM 
constituents.  For example, Danisovic et al 2007 demonstrated that TGFβ I treatment 
leads to increased collagen type II and aggrecan gene expression (85). Similarly, Thrope 
et al 2010 showed that TGFβ 3 increases the level of glycosaminoglycan synthesis of 
MSCs (86).  
  Other common constituents of chondrogenic medium include insulin, selenium, 
transferrin, ascorbic acid and dexamethasone. Insulin is a peptide hormone produced by β 
cells of the pancreas in order to modulate glucose metabolism. Systemic insulin binds to 
cell surface insulin receptors and induces the translocation of glucose transporters to the 
plasma membrane in order to increase cellular glucose influx (87). Mueller et al. 2013 
demonstrated that insulin is required for human MSC chondrogenic differentiation and 
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showed that a positive correlation exists between the insulin dosage and the synthesis 
glycosaminoglycan and collagen of MSCs (88). Transferrin is an essential protein that is 
known to transport iron into cells, where iron aides in facilitating the hydroxylation of 
proline required for collagen synthesis and selenium is an essential trace element that 
increases the activity of glutathione peroxidases in protecting cells from oxidative stress 
(89-91). Additionally, ascorbate is a cofactor required in the production of collagen type 
II synthesis in chondrocytes and has been observed to influence glycosaminoglycan 
synthesis (92, 93). Dexamethasone is a synthetic glucocorticoid and is also commonly 
included in chondrogenic media in order to increase collagen type II synthesis by 
increasing levels of Sox9 in MSCs (94). In addition to media supplements, MSCs may be 
formed into a cell pellet by centrifugation prior to differentiation. It is postulated that the 
induced mechanical force and limited oxygen supply that accompany this cell formation 
aid in the commitment of MSCs to the chondrogenic lineage (95).  
1.5.3 Adipogenesis (white adipose) 
The mature adipocyte contains a single large fat droplet surrounded by a thin rim 
of cytoplasm that lies between the droplet and the plasma membrane. When triggered by 
lipolytic hormones, fatty acids are derived from triglycerides within the fat droplet by 
cytoplasmic hormone-sensitive lipase and adipocyte-triglyceride lipase that translocate to 
the surface of the droplet. The fatty acids are then released into the blood stream to 
supply peripheral tissues. During periods of excess caloric intake, lipogenic enzymes 
localize in the cytoplasm and endoplasmic reticulum, synthesize triglyceride, which is 
incorporated into the fat droplet (102). 
16 
 
 At approximately the beginning of the second third of gestation, large and small 
arterioles can be detected in the vicinity of small developing fat cell clusters at various 
sites (buccal, neck, shoulder, perirenal). Adipose appears and develops in these areas 
where it remains after birth. Primitive fat cell clusters are then formed, composed of 
densely packed fat cells adjacent to capillaries. The last stage of growth of adipose is 
mainly due to an increase in size of fat cell clusters surrounded by mesenchymal stroma, 
which condenses rapidly and then thickens to form septa among the clusters (103). The 
development of MSCs into terminally differentiated adipocytes occurs as discrete phases. 
The first being the commitment phase in which the stem cell is converted into a 
preadipocyte. The preadipocyte cannot be distinguished morphologically from its 
precursor but has lost the potential to differentiate into other cell types. The events 
governing the commitment phase have not been well characterized, largely because of the 
predominant use of preadipocyte cell lines to study adipogenesis. Following commitment 
to the adipogenic lineage, preadipocytes will experience period of growth arrest at the the 
G1/Go cell cycle boundary.  Preadipocytes receiving appropriate mitogenic and 
adipogenic signals will then synchronously re-enter the cell cycle and undergo several 
rounds of cell division referred to as mitotic clonal expansion. As cells complete clonal 
expansion, terminal differentiation occurs which is characterized by expression of the 
enzymatic machinery required for lipogenesis and triacyl glycerol synthesis which is 
responsible for lipid accumulation within the differentiated adipocyte (104). 
 The central regulator of adipogenesis is the transcription factor peroxisome 
proliferator-activated receptor γ (PPARγ). When activated, PPARγ interacts with the 
retinoid x receptor, forming a heterodimer which binds DNA at peroxisome proliferator 
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response elements in the promoter of target genes. The binding of the heterodimer is 
required for the activation many adipocyte specific genes involved lipid breakdown and 
storage (105). The importance of PPARγ in adipogenesis has been demonstrated in 
several ways. For example, the overexpression of PPARγ in non-adipogenic fibroblasts 
produces cells with an adipocyte-like phenotype (106). Moreover, Rosen et al. 1999 
created chimeric mice derived from both wild-type embryonic stem cells and cells with a 
homozygous depletion of PPARγ. This strategy allows for the measurement of the 
contribution of PPARγ null cells to others tissues in healthy animals (107). The 
researchers observed that null cells were excluded from WAT but not several other 
tissues. Moreover, PPARγ heterozygotes animals exhibit resistance to diet-induced 
obesity (108).  
  In order to induce adipogenesis of MSCs in vitro, culture medium is 
supplemented with specific hormones such as insulin and synthetic compounds including 
3-isobutyl-1-methylxanthine (IBMX), dexamethasone, and rosglitazone. Insulin is a 
polypeptide hormone that binds to cell surface insulin receptors (IR) in order to initiate a 
number of downstream signaling cascades (87). The presence of insulin appears to be 
required for in vitro adipogenic differentiation. However, the mechanism through insulin 
induces adipogenesis is not fully understood. The loss of insulin-receptor substrate (IRS), 
a signaling protein activated by IR, inhibits adipogenesis (109). Moreover, the specific 
inhibition of phosphatidylinositol 3-kinase (an effector protein activated by IRS) also 
blocks adipogenesis (110). Rosglitazone is a potent PPARγ agonist. Rosiglitazone 
treatment increases the adipogenic response in vitro and increases the number of 
adipocytes in dogs and rats (111). Through the activation of PPARγ, rosiglitazone 
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initiates the expression of a number of adipogenic genes (105). Furthermore, IMBX is a 
phosphodiesterase inhibitor increases intracellular cyclic adenosine monophosphate 
(cAMP) levels. cAMP subsequently activates the cAMP response element-binding 
protein (CREB) which increases PPARγ expression (105). Lastly, dexamethasone is a 
synthetic glucocorticoid which activates glucocorticoid receptors. The adipogenic 
differentiation of MSCs is accelerated by dexamethasone increases the expression of 
adipogenic transcription factors PPARγ and C/EBPα (CCAAT/enhancer binding protein 
α) (105).     
1.5.4 Adipogenesis (Brown adipose and Brite cells) 
Brown adipose tissue (BAT) tissue develops during embryogenesis within 
intrascapular regions and peripheral tissues and is the key site of heat production in small 
mammals and infant humans.  The heat produced by brown adipocytes is a result of the 
non-shivering thermogenesis pathway (112). Deficits in body temperature are recognized 
by the central nervous system and are relayed via sympathetic neurons which releases 
norepinephrine (NE) at BAT depots. Subsequently, NE binds to surface β3-adrenergic 
receptors which initiate the breakdown of stored triglycerides into fatty acids that activate 
UCP1. These fatty acids can also be oxidized by mitochondria. However, this potential 
energy of the proton motive force established by respiration is in part dissipated by 
protons transporting through UCP1 instead of ATP-synthase, resulting in increased 
oxygen consumption and substrate oxidation. Ultimately, lipid oxidation by brown 
adipocytes releases energy in the form of heat which is transferred throughout the 
organism via the circulatory system, thus warming the organism (112).  
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Compared to infants and small mammals, the amount of BAT within adult 
humans is relatively small (12). Interestingly, in addition to BAT cells, populations of 
inducible brown adipocyte-like cells, known as brite cells have also been found within 
WAT. Brite cells arise in WAT from resident populations of stem cells. Morphologically, 
brite cells resemble brown adipocytes, possessing lipid droplets and a high mitochondrial 
content. Moreover, brite cells express UCP1 and the signal transduction pathway that 
regulates non-shivering thermogenesis in response to NE (113, 114). In order to induce 
the differentiation of WAT derived stromal vascular fraction (SVF) stem cells into brite 
cells in vitro, inducers of UCP1 expression have been utilized. The promoter region of 
the ucp1 gene contains cyclic AMP (cAMP) response elements (CRE) in addition to a 
peroxisome proliferator activated receptor (PPAR) response element (PPRE) and a 
thyroid hormone response element (TRE). In the presence of NE, brown adipocytes 
experience an increase in the concentration of phosphorylated cAMP binding protein 
(pCREB) (112). Rim & Kozak 2002 reported that pCREB binds to CRE in the ucp1 
promoter region and activates its transcription (115). Similarly, synthetic agonists of the 
transcription factor peroxisome proliferator receptor γ (PPARγ) such as rosiglitazone and 
indomethacin activate PPARγ, causing it to bind to PPRE in the promoter region of ucp1 
and increase transcription (112). Furthermore, in the presence of triiodothyronine (T3), 
thyroid receptors translocate to the nucleus and bind TRE and in turn enhance ucp1 
expression (112). Recent investigations have reported that incubating WAT derived SVF 
cells with T3 combined with PPARγ and/or NE is sufficient to induce the differentiation 
into brite cells capable of initiating a thermogenic response to NE (116-120).  
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 In addition to specific stimulators of UCP1, IBMX in combination with insulin 
and dexamethasone is commonly utilized to induce brite cell and brown adipocyte 
differentiation (116-121). IBMX increases cAMP levels through the inhibition of 
degradation cAMP phosphodiesterases (122), thus increasing CRE activity. Insulin and 
dexamethasone (a synthetic glucocorticoid) interact with IR and glucocorticoid receptors 
(GC receptors), respectively (123). Little is known concerning the specific molecular 
mechanisms of these molecules in the differentiation process. However, the presence of 
glucocorticoid alone induces differentiation of brown adipocytes in vitro (124). 
Moreover, the presence of insulin and the activation of its downstream effector, IRS, is 
necessary for brown adipogenesis (125). 
1.6 Therapeutic use and potential of MSCs 
 The ability of MSCs to differentiate into osteoblasts, chondroblasts, and brite cells 
has attracted much interest for their use in combating age-related pathologies. Moreover, 
MSCs are ideal for regenerative therapies due to the fact that they do not induce adverse 
immune responses in autologous (self) or allogeneic (separate individual) transplants.  
Firstly, the osteogenic potential of MSCs has benefit in an orthopedic setting (126). 
Osteoporosis is a condition of older individuals and is characterized by skeletal fragility 
due to progressive bone loss. Bone becomes sufficiently weak that fractures occur with 
minimal trauma (127). The use of MSCs for fracture repair has been tried successfully in 
animal models. Autologous bone marrow-derived MSCs have been expanded in culture, 
loaded onto ceramic cylinders, and implanted into 8-mm segmental defects in rat femurs 
with successful bone formation 8 weeks later (128). The same group then successfully 
demonstrated bone formation in segmental defects in adult rats by human marrow-
21 
 
derived MSCs (129). Several other animal studies using implanted autologous MSCs 
have also resulted in successful bone regeneration (130, 131).  Thus, the injection MSCs 
into bone defects is a promising therapy to treat fractures caused by age-related 
osteoporosis.  
 In addition to bone repair, MSCs also have applications in regenerating cartilage 
tissue.  Osteoarthritis is a disease with a high prevalence among elderly adults. 
Osteoarthritis is characterized by degeneration of the cartilaginous lining of joints of long 
bones causing pain and limited mobility (132). MSC transplantation has been shown to 
be effective for cartilage repair in animal models and human patients. For example, 
Murphy et al. 2003 intra-articularly injected goats in which osteoarthritis was induced by 
surgery (133). Labelled MSCs were not found in large numbers in the cartilage area. 
However, regeneration of the tissue was clearly evident in animals receiving cells in 
comparison to controls. Similarly, undifferentiated and pre-differentiated MSCs on 
scaffolds yielded cartilage repair in rabbits and sheep models of osteoarthritis. Human 
trails demonstrated beneficial effects of MSCs for osteoarthritic patients. For example, 
Orozco et al. 2013 identified radiological evidence of osteoarthritis in 12 patients (134). 
Individuals were then treated with autologously expanded marrow MSCs by intra-
arctcilar injection. Following 1 year 11 out of 12 patients displayed improved cartilage 
quality in the treated areas. Taken together, MSCs based therapy is a promising strategy 
to ameliorate the symptoms of age-associated osteoarthritis. 
 Sedentary living and the consumption of calorie-dense food has led to a rise in 
obesity throughout the developed world. This is especially true in the elderly, among 
whom obesity-associated pathologies such as hyper-tension, type 2 diabetes, 
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hyperglycemia, are highly prevalent (135, 136). Obesity-related conditions often arise 
due to a misbalance in energy intake relative to expenditure, resulting in excess energy 
stored as lipid in WAT (135). Thus, increasing non-shivering thermogenic activity is a 
potential strategy to combat obesity. Investigations into the relationship between non-
shivering thermogenesis and lipid metabolism have revealed that enhanced BAT activity 
is capable of conferring anti-obesity properties. For example, Feldmann et al. 2009 
developed UCP1-defiecient mice and demonstrated that transgenic mice gained more 
weight than wild-type animals (137). Similarly, overexpression of UCP1increases 
thermogenesis and prevents weight gain (138, 139). Moreover, mice with increased BAT 
activity display improvements in conditions associated obesity such as increased insulin 
sensitivity and glucose tolerance (140, 141).  Considering that resident MSCs in WAT 
depots possess the ability to differentiate into BAT-like cells, increasing thermogenic 
activity by inducing MSC differentiation into brite cells is a potential strategy to combat 
obesity. 
The transplantation of cells between individuals of the same species (allogeneic 
transplantation) not receiving immune suppressive therapy typically results in rejection 
due to cell death caused by activation of host immune systems. An accumulating body of 
evidence suggests that allogeneic MSCs suppress host immune cells allowing them to 
avoid rejection (142). Following tissue implantation, host lymphocytes become activated 
as part of the innate immune response. Activated lymphocytes subsequently proliferate 
and then differentiate into effector cells that infiltrate foreign tissues causing apoptosis 
within the transplant (143). In 2002, Bartholomew et al. showed that the addition of 
primary MSCs to cultures of pre-activated allogeneic lymphocytes suppressed 
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lymphocyte proliferation (144). In order to test the immune suppressive potential of 
MSCs in vivo, allogeneic skin grafts were performed on baboons following injection of 
donor matched MSCs. The authors observed that MSCs extended graft survival from 7 
days (no MSC control) to 11 days. Furthermore, Liechty et al. 2000 reported that human 
MSCs could persist as long as 13 months after injection into pre-immune (immune 
system has not developed) and immune competent fetal sheep (145). In contrast human or 
allogeneic hematopoietic stem cells did not persist in this model. Taken together, the 
above evidence suggests that allogeneic MSCs do not provoke adverse immune 
responses. Considering this, MSCs may potentially be isolated and stored either for 
autologous (self-transplant) or allogeneic transplantation.       
1.7 Project Objectives 
MSCs isolated from adipose tissue are an ideal source of stem cells because they 
are easily accessible and possess the ability to differentiate into specialized cell types. 
However, several unique challenges currently limit the usefulness of adipose as a source 
of MSCs for regenerative medicine. The majority of cells within adipose stroma are non-
MSC cell types such as fibroblasts, endothelial cells, and hematopoietic cells. Because 
MSCs represent a small fraction of total stromal cells, adipose stromal suspensions 
diluted with non-MSC cells may possess a limited differentiation capacity. Furthermore, 
MSCs from adipose have traditionally been isolated using collagenase in order to liberate 
stromal cells from the surrounding extra-cellular matrix. This method is not ideal because 
the sample will be contaminated with potentially toxic exogenous enzyme that cannot 
enter a patient. Moreover, recruitable populations of brite cells are believed to reside 
within WAT depots. Recent evidence suggests that inducers of UCP1 expression can 
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stimulate resident WAT MSCs to differentiate into brite cells. With the above issues in 
mind, the overall purpose of this thesis is to further develop novel methods for isolating 
and differentiating adipose-derived MSCs into desired cell types. 
This Thesis addresses the following questions: 
1. Does the removal of non-MSC cell (fibroblast, endothelial, hematopoietic) 
cell types from a heterogenous population of adipose stromal cells increase 
the proportion of stem cells capable of differentiation in vitro? 
2. Can MSCs be isolated from Human adipose using a non-enzymatic method 
with an efficiency comparable to the collagenase based method? 
3. Can differentiation medium containing known stimulators of UCP1 
expression induce the differentiation of WAT stromal cells into 
thermogenically competent brite cells? 
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Chapter 2: Development of isolation, enrichment, and differentiation protocols for 
adipose derived stem cells using rat adipose tissue 
 
 
 
Objectives: Assess effectiveness of standard protocols for the isolation, adipogenic 
differentiation, and ostegenic differentiation on stromal vascular cells isolated from rat 
adipose. Furthermore, to determine if removal of non-mesenchymal stem cell (fibroblast, 
endothelial, hematopoietic) cell types from a heterogenous population of rat adipose 
stromal cells will increase the proportion of stem cells capable of differentiation in vitro.  
 
Hypothesis: MSCs will be isolated from rat adipose. Depletion of non-mesenchymal 
stem cells from the heterogeneous population of stromal vascular cells will give rise to an 
enriched MSC culture capable of differentiation into osteoblasts and adipocytes. 
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Abstract 
 The majority of cells within tissue stroma are non-MSC cell types such as 
fibroblasts, endothelial cells, and hematopoietic cells. MSCs represent a small fraction of 
total stromal cells. Thus, cultures diluted with non-MSC cells may possess a limited 
differentiation capacity. Adherent, proliferative stromal cultures were established from 
rat adipose and bone marrow. Cultures were subsequently exposed to medium containing 
inducers of adipogenic or osteogenic differentiation. Following the differentiation 
treatment period, oil red o and alizarin red staining for adipose and bone differentiation, 
respectively, was performed. Staining revealed that minimal adipogenic differentiation 
was achieved while osteogenic differentiation was absent in stromal cultures. Separate 
groups of stromal cells were then incubated with anti-CD 54, 45, and 31 antibody-coated 
magnetic beads and subjected to magnetic sorting in order to remove non-MSC stromal 
cells. Cell counting following sorting showed that the separation process removed bead 
bound cells from cell suspensions. However, neither sorted nor non-sorted stromal cells 
experienced a strong differentiation response.  These results suggest that the removal of 
non-MSC stromal cells had no effect on the osteogenic or adipogenic capacity of stromal 
cultures. Moreover, a lengthy culture period was utilized prior to sorting. It is likely this 
extended culture period affected the differentiation capacity of the stromal cells. Thus, 
future work should assess separation procedures that minimize the time cells spend in 
vitro prior to differentiation.  
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2.1 Introduction 
 Mesenchymal stem cells (MSCs) comprise a minute percentage of total cells 
(>1%) present within adipose tissue. The majority of cells within the tissue stroma are 
cells of hematopoietic origin such as erythrocytes and leukocytes or connective tissue 
cells such as adipocytes, fibroblasts and endothelial cells (33). Therefore, during any 
protocol for isolation of MSCs from adipose tissue stroma a heterogeneous population of 
cells will initially be obtained.  Because of this plurality of cell types, the cell population 
established from adipose tissue may not display a robust differentiation response when 
analyzed using histochemical techniques, compared to a culture with a higher proportion 
of stem cells.  Moreover, it can be difficult to obtain a large number of adipose derived 
cells and these may be significantly diluted by non-MSCs, thus it is necessary to develop 
methods to maximize both the yield and ‘purity’ of MSCs from adipose tissue. Since it 
was anticipated that access to human adipose tissue samples would be extremely limited, 
it was necessary to develop the methodology for isolating and enriching stromal vascular 
derived MSCs using a more readily available source of adipose tissue.  The laboratory rat 
Rattus norvegicus was chosen because of its convenience as an experimental model, 
availability, and the size of adipose stores that could be isolated. Therefore, in this 
chapter, rats were used to establish the collagenase-based digestion protocol for isolating 
MSCs from the adipose stromal vascular fraction, to establish and validate protocols for 
differentiating (and for evaluating differentiation) MSCs into adipocytes, osteocytes, and 
to test an immuno-magnetic negative selection method for enriching MSCs. 
With respect to the enrichment of MSCs, according to IFATS adipose-derived 
MSCs should express CD34, CD13, CD73, CD90, CD105 and be negative for CD45, 
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CD235a, CD31 (33). However, the surface antigen profile attributed to adipose derived-
MSCs is highly variable between research groups (table 1.1). In contrast, many non-MSC 
stromal cells express unique surface antigens that can be used for cell sorting and 
selection. For example endothelial cells express CD31, fibroblasts express CD54, and 
cells hematopoietic cells express CD45 while MSCs do not (33, 59, 49, 147). With these 
issues in mind, a negative selection strategy was explored to enrich the MSC by 
removing these other cell types.    
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2.2 Materials and Methods 
2.2.1 Materials 
3-isobutyl-1-methylxanthine (IBMX), ascorbate-2-phosphate seqimagnesium salt 
hydrate, biotin, β-glycerophosphate disodium salt, bovine serum albumin  (BSA) fraction 
V, cetylpyridium chloride, dexamethasone, d- pantothenate, dimethyl sulfoxide (DMSO), 
fetal bovine serum (FBS), Hank’s balanced salt solution, low glucose Dulbecco’s 
modified eagles media (DMEM) powdered media, human recombinant insulin, 
paraformaldehyde, penicillin/ streptomycin, rosiglitazone, and 0.25% trypsin-EDTA were 
purchased from Sigma Aldrich. 
 Calcium chloride, glutamine, HEPES, potassium chloride, potassium diphosphate, 
monobasic potassium phosphate, sodium bicarbonate, sodium chloride, sodium 
hydroxide and dibasic sodium phosphate were purchased from Fischer Scientific. 
 DMEM/ F-12 powdered media with L-glutamine, and Ham’s F-12 powdered 
media with L-glutamine were purchased from Invitrogen. Collagenase type I was 
purchased from Worthington Biochemical. Hydrochloric acid, isopropanol, and sodium 
hydroxide were purchased from Caledon. Alizarin red and oil red O were purchased from 
Santa Cruz Biotechnology. Biotinylated anti-rat CD54 and CD45 were purchased from 
Biolegend. Biotinylated anti-rat CD31 was purchased from BD biosciences. M-280 
streptavidin coated Dynabeads were purchased from Invitrogen. Sodium pentobarbital 
was purchase from Bimeda-MTC animal health Inc. Isoflurane was purchased from 
Pharmaceutical Partners of Canada. 
 3T3-L1 cell line was purchased from Eton Biosciences. Saos-2 cell line was a gift 
from the Dr. Ward lab (Brock University, St. Catharines, Ontario, Canada). 
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2.2.2 Animals and primary cell line isolation 
 The use of experimental animals was approved by the Brock University ACUC. 
Animal euthanization: young adult Long Evans rats were euthanized using either 
decapitation with a guillotine, pentobarbital sodium injection (2ml/ 4.5kg body weight) or 
inhalation of isoflurane plus heart excision using the Dispomed Moduflex Compact 
anesthesia machine. (table 1). Adipose derived stromal vascular cells: excised intra-
peritoneal adipose tissue was subjected to collagenase digestion. Tissue was minced and 
washed multiple times with warm PBS until a clear infranatant solution was obtained. An 
equal volume of warm collagenase solution (0.1 % collagenase type I, 1% BSA in PBS) 
was added to the tissue and shaken at 75 RPM for 60 min using the Laboratory Water 
Bath Shaker Model G76 (New Brunswick Scientific). Digested tissue was vortexed for 
15 seconds and subsequently centrifuged at 350 x g for 5 minutes using the Sorvall RC 
5C Plus centrifuge. Samples were then vortexed again for 10 seconds. Samples were 
again centrifuged for 5 minutes at 350 x g. The supernatant of oil and collagenase 
solution was subsequently removed. Cells were then re-suspended in PBS and 
centrifuged at 350 x g for 5 minutes. The supernatant was then removed and cells were 
re-suspended in growth media (DMEM/ F-12, supplemented with 2.438 g/L sodium 
bicarbonate, 10% FBS, 1% penicillin/streptomycin). Cells were seeded on either 60mm 
or 100mm tissue culture treated dishes (Sarstedt) at ~0.16 ml tissue/cm2 (2).  
Bone marrow derived stromal vascular cells: Femurs from euthanized rats were 
excised and removed of muscle and connective tissue. Femurs were subsequently placed 
in cold Hank’s balanced salt solution (HBSS) for 5 min. Using bone cutting scissors, the 
ends of femurs were removed. Subsequently, the marrow plug was flushed from the bone 
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using a 27 gage needle filled with cold HBSS. The marrow plug was re-suspended into a 
cell suspension and centrifuged at 350 x g for 10 min. The cell pellet then was re-
suspended in growth media (Low glucose DMEM supplemented with 10% FBS, 5.96 g/L 
HEPES, 1% penicillin/streptomycin). Cells were seeded on tissue culture treated dishes 
(Sarstedt) at a density of 1.94 x 106 cells/cm2 (17).  
2.2.3 Cell Culture:   
 Stromal vascular cells obtained from either adipose or bone marrow were cultured 
in growth media at 37˚C, 5% CO2 and 3% O2. Once passage 0 cultures reached ~70-80% 
confluence the cultures were split at a ratio of 1:2 using 0.25% trypsin-EDTA solution.  
Adipose derived cells were further subcultured for 1-2 more passages, allowed to reach 
confluency, placed on 60mm plates and exposed to osteogenic medium or media 
containing vehicle controls. Alternatively adipose derived or bone marrow derived cells 
were subcultured until passage 5 and subjected to magnetic separation. Following 
separation cells were plated on a 100 mm tissue culture treated dish and allowed to reach 
confluency (passage 6). Subsequently, cells were exposed to trypsin and plated on 35 mm 
tissue culture treated dishes (NEST) at a density of 15 000 cells/cm2. Once reaching 
confluency cells were transferred to a 20% O2 incubator and were treated with 
differentiation treatments or corresponding vehicles. 
 Osteogenic Treatment: cells were cultured in growth media supplemented with 
0.1 M dexamethasone dissolved in DMSO, 0.01M -glycerophosphate and ascorbate-2-
phosphate dissolved in media for 21 days (18). Osteogenic control cells were cultured in 
growth media supplemented with an equivalent amount of DMSO (0.01%) until reaching 
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until 90-100% confluence (6 days). Osteogenic and control media was changed every 2 
days. 
 Adipogenic Treatment:  cells were cultured in adipogenic media consisting of: 
growth medium supplemented with 3% FBS, 1% pencilin/streptomycin, 200 nM human 
insulin dissolved in 4mM HCl, 66 M biotin dissolved in 1M NaOH, 0.25 mM IBMX 
dissolved in DMSO, 34 uM pantothenate dissolved in water, 1 M dexamethasone 
dissolved in ethanol, 5 mM and rosiglitazone dissolved in DMSO for 3 days. At day 4 of 
treatment, adipogenic cells received adipogenic maintenance media (adipogenic media 
without IMBX or rosiglitazone) for 8 days (19). Adipogenic control plates received 
growth medium supplemented with 3% FBS, 1% pencilin/streptomycin, 0.2% DMSO, 
0.1% ethanol, 0.1% 1M NaOH, and 0.1% 4mM HCl until cells reached 90-100% 
confluence (6 days). Adipogenic and control media was changed every 3 days. 
Osteosarcoma cells: Saos-2 human osteosarcoma cells were seeded on 35 mm 
tissue or 60mm culture treated plates at 10 000 cells/cm2. Cells were cultured in Ham`s F-
12 supplemented with 10% FBS, 1% penicillin/streptomycin, 28 mM HEPES, 1.1 mM 
CaCl2, and 2.0 mM L-glutamine and incubated at 3% O2, 5% CO2. At 70-80% 
confluence, cells were moved to 20%, O2, 5% CO2 and cultured in osteogenic media 
consisting of Ham’s F-12 supplemented with 50 μM ascorbate-2-phosphate, and 10 nM 
-glycerophosphate dissolved in media and 0.1 M dexamethasone dissolved in DMSO 
for 21 days. Control cells received growth media supplemented with an equivalent 
amount of DMSO (0.01%) for 6 days. Control and osteogenic media was changed every 
2 days. 
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 Preadipocytes:  3T3-L1 mouse preadipocyte cells were seeded on 35 mm tissue 
culture treated plates at 10 000 cells/cm2. Cells were cultured in high glucose DMEM 
supplemented with 10% FBS, 1% penicillin/streptomycin at 37˚C, 5% CO2, 3% O2. At 
90-100% confluence, cells were moved to 20% O2, 5% CO2 and were cultured in 
adipogenic media consisting of: DMEM/ F-12 supplemented with 3% FBS, 1% 
penicillin/ streptomycin, 200 nM human insulin dissolved in 4mM HCl, 66 M biotin 
dissolved in 1M NaOH, 0.25 mM IBMX dissolved in DMSO, 34 uM pantothenate 
dissolved in water, 1 M dexamethasone dissolved in ethanol, 5 mM and rosiglitazone 
dissolved in DMSO for 3 days. At day 4 of treatment, adipogenic cells were received 
adipogenic maintenance media (adipogenic media without IMBX or rosiglitazone) for 8 
days. control plates received DMEM/F-12 supplemented with 3% FBS, 1% penicillin/ 
streptomycin, 0.2% DMSO, 0.1% ethanol, 0.1% 1M NaOH, and 0.1% 4mM HCl until 
cells reached 90-100% confluence (6 days). Control and adipogenic media was changed 
every 3 days. 
 
2.2.4 Magnetic Separation 
 Magnetic separation was conducted according to manufacturer’s instructions. The 
following process was performed in a series of 3 isolation events conducted in 
succession, each with a different antibody. The first isolation used anti- CD 31 
antibodies, the second anti-CD 54 antibodies, and the third anti-CD 45 antibodies. 0.25 
mg of streptavidin conjugated magnetic beads (Dynabeads) were washed by being placed 
in an eppendorf tube containing cold isolation buffer (PBS supplemented with 2mM 
EDTA and 0.1% FBS). Subsequently, beads were taken out of solution using the 
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DYNAL magnet (Invitrogen) for 1 min. The supernatant was removed and the beads 
were resuspended in fresh isolation buffer.  2.5ug of antibody was placed into the tube 
containing pre-washed beads suspended in isolation buffer. Beads were incubated with 
antibody for 30 min with gentle rocking. Antibody conjugated beads were washed with 
isolation buffer using the DYNAL magnet and then incubated with 1 x 107 passage 5 cells 
derived from either adipose or bone marrow. Cells and antibody conjugated beads were 
incubated at 4oC with gentle rocking for 30min. Bead-bound cells were separated from 
unbound cells using the Dynamag 15 magnet (Life technologies) for 2 min. The 
superanatant containing unbound cells was transferred to a fresh tube. Unbound cells 
were then counted using a hemocytometer. The unbound cells were subsequently 
centrifuged, resuspended in growth media and seeded on a 100 mm tissue culture treated 
plate.   
2.2.5 Staining 
Alizarin red: Osteogenic differentiation was detected using alizain red staining. 
Cells were prepared for staining by fixation in 4% paraformaldehyde (pH 7) solution at 
4˚C overnight. Fixed cells were incubated in 40 mM alizarin red solution (pH 4.2) for 20 
min. Following staining, excess dye was removed with distilled water (20). Oil Red O: 
adipogenic differentiation was detected using oil red O staining. Cells were prepared for 
staining by fixation in 4% paraformaldehyde (pH 7) solution at 4˚C overnight.  Oil red O 
was prepared as 0.35% stock in 99% isopropanol. At time of use a 60% working solution 
was made by diluting stock solution in distilled water. The working solution was mixed 
and allowed to sit for 30 min and filtered before use. Fixed cells were incubated in 60% 
working solution for 1 hour. Excess dye was removed with distilled water (21). 
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2.2.6 Dye elution 
Osteogenic differentiation was assessed by measuring the absorbance of alizarin 
red eluted from stained cells. Alizarin red was eluted by placing cells in 10% 
cetylpyridinium chloride (CPC) dissolved in 10mM sodium phosphate for 1 hour (7). 
Adipogenic differentiation was assessed by measuring the absorbance of oil red o eluted 
from adipogenic and control plates. Oil red o was eluted by placing stained cells in 99% 
isopropanol (elution of dye is immediate) (8). Alizarin red and oil red O elutant solutions 
were pipetted into 96 well flat optical bottom plates (Nalge Nunc International). The 
absorbance of the alizarin red elutant was read at 550nm and the absorbance of the oil red 
O elutant was read at 540 nm using the Bio-Tek Powerwave HT Microplate 
Spectrophotometer and KC4 software. 
2.2.7 Imaging 
Bright field and phase contrast images of cells in culture were captured using the 
Hund Wilovert S inverted microscope from Fischer Scientific. Bright field images of 
stained cells and were obtained using the Nikon eclipse 80i microscope. 
2.2.8 Statistical analysis 
 Dye elution and ImageJ data were analyzed using the Student’s T-Test with a one 
tailed distribution. Data were analyzed on GraphPad Prisim version 5. α= 0.05 was used 
to determined statistical significance.  In each analysis, technical replicates (individual 
cultures) were treated as biological replicates in order to achieve statistical significance.  
 
Table 2.1: Method and purpose of separate animal euthanizations 
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Gender Euthanization Method  Tissue harvested Use of tissue 
(results 
section) 
Female Decapitation Adipose 2.4.1 
Female Decapitation Adipose 2.4.1 
Female Decapitation Adipose 2.4.1 
Female Pentobarbital Sodium Adipose 2.4.2 
Female Isoflurane + heart excision Adipose 2.4.2 
Female Isoflurane + heart excision Adipose, Bone marrow 2.4.2-2.4.3 
Female Isoflurane + heart excision Bone marrow 2.4.3 
Female Isoflurane + heart excision Bone marrow 2.4.3 
 
2.3 Results 
2.3.1 Preliminary isolation of rat adipose SVF cells 
It was anticipated that human adipose tissue available for experimentation would 
be limited. Considering this, it was desirable to develop a method of isolating SVF cells 
using rat adipose prior to using human tissue. Adipose from three young adult rats was 
subjected to collagenase digestion and the stromal vascular cells obtained were 
subsequently placed in growth medium and seeded onto tissue culture dishes. 
Collagenase digestion yielded cultures containing proliferative cells which achieved 
approximately 80-90% confluence 2-4 days following seeding (Figure 2.1). 
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Figure 2.1. Rat adipose-derived stromal vascular cells in culture following collagenase 
digestion. Image at 4x magnification. 
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2.3.2 Osteogenic differentiation of adipose derived SVF cells 
 A central feature of MSCs in vitro is the ability to undergo osteogenic, 
adipogenic, and chondrogenic differentiation. The combination of dexamethasone, 
ascorbic acid, and β-glycerophosphate supplemented into growth medium has been 
previously demonstrated to induce osteogenic differentiation of MSCs in vitro (148). In 
order to determine if cells isolated from rat adipose were capable of osteogenesis, cells 
were cultured in the presence of osteogenic differentiation medium consisting of 50 μM 
ascorbate-2-phosphate, 10 nM -glycerophosphate, and 0.1 M dexamethasone for 21 
days (n=9). Following the treatment period, cultures were fixed and stained with alizarin 
red to assess whether the cells produced a calcified matrix. 
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 Saos-2 osteosarcoma cells are an immortal cell that have been previously 
demonstrated to undergo osteogenic differentiation and was used here as a positive 
control of osteogenic differentiation.  Saos-2 cells (n=3) were exposed to the same 
treatment and staining conditions as adipose derived cells. Saos-2 cells cultured in 
differentiation medium displayed a high level of staining throughout the culture 
monolayer compared to those cultured in control medium (Figure 2.2 a, b). Compared to 
differentiated Saos-2 cells, cultures derived from adipose tissue displayed a level of 
staining more similar to adipose derived cultures that received vehicle alone than 
differentiated osteoblasts. In order to compare the level of osteogenic differentiation 
between groups, the amount of alizarin red staining was assessed by eluting the dye 
retained by each sample. The absorbance of the dye elutant was subsequently measured at 
550 nm (Figure 2.3 a, b). The dye elution data were analysed using the unpaired 
Student’s T-Test with a one-tailed distribution. A large significant increase in the amount 
of alizarin red occurred between Saos-2 cultures that received treatment and those that 
did not (p-value > 0.0001). No difference was observed between adipose derived SVF 
cultures that received differentiation medium and those that received vehicle (p-value 
0.4019). Considering the above, it is likely that the adipose derived cultures obtained 
using collagenase digestion did not undergo osteogenic differentiation.  
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Figure 2.3. Alizarin red stain elution of adipose SVF cells following magnetic isolation (A) and Saos-2 
cells (B). Absorbance read at 550 nm of alizarin red eluted from adipose SVF and Saos-2 cells cultured in 
osteogenic differentiation media (Treatment) or control media (Ctrl). Data points represent measurements 
made in triplicate, +/- standard error. Data points labelled treatment represent samples diluted in CPC at a 
ratio of 1:3, the absorbance values of these samples were then multiplied by a factor of 3.  Saos-2 data 
point labelled treatment represents samples diluted in CPC at a ratio of 1:10, the absorbance values of 
these samples were then multiplied by a factor of 10. Individual cultures are used as replicates, where n=9 
for adipose derived cultures and n=3 for Saos-2 cultures.* indicates a significant difference (P < 0.05).  
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D C 
Figure 2.2. Alizarin red staining of adipose SVF cells and Saos-2 cells.  Adipose SVF cells 
(b, d) and Saos-2 cells (a, c) received either osteogenic medium for 21 days (c, d) or 
growth medium supplemented with vehicle control for 5 days (a, b).  Following culture, 
cells were fixed and stained with alizarin red. Images taken at 10x.  
* 
B A 
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2.3.3 Adipogenic differentiation of adipose derived SVF cells 
Previous research has demonstrated that a combination of human insulin, biotin, 
IBMX pantothenate, dexamethasone, and rosiglitazone supplemented into growth 
medium is sufficient to differentiate MSCs into adipocytes. In order to determine if rat 
adipose-derived cells were capable of adipogenesis, cultures were treated with the above 
supplements for 12 days. Furthermore, the mouse pre-adipocyte cell line, 3T3-L1, is 
often used as a model of in vitro adipogenesis. As a positive control for adipogenic 
differentiation cultures of 3T3-L1 cells received identical treatment conditions as rat 
adipose derived cells. Following the culture period, cells were fixed and stained with oil 
red o to detect the production of lipid droplets within cells. 3T3-L1 cells (n=3) treated 
with adipogenic medium displayed a high level of staining, indicating a robust 
differentiation response (Figure 2.4 c). In comparison, adipose derived cells (n=8) 
displayed a low level of staining, with only a small number of positively stained cells 
observed (Figure 2.4 d). In order to further compare the level of adipogenic 
differentiation between groups, the amount of oil red o staining was assessed by eluting 
the dye retained by each sample. The absorbance of the dye elutant was subsequently 
measured at 540 nm (Figure 2.5). The dye elution data were analysed using the unpaired 
Student’s T-Test with a one-tailed distribution. A significant difference in the level of 
staining between control and treatment cultures of 3T3-L1 cells was observed (p-value > 
0.0001). However no statistical difference between adipose-derived treatment and control 
cultures was observed (p-value 0.1774). 
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Figure 2.5. Oil red o stain elution of adipose SVF cells and 3T3-L1 cells.  Absorbance read at 540 nm of oil red o 
eluted from adipose SVF and 3T3-L1 cells cultured in adipogenic differentiation media (Diff) or control media 
(Ctrl). Data points represent measurements made in triplicate, +/- standard error. Individual cultures are used as 
replicates, where n=8 for adipose derived cultures and n=3 for 3T3-L1 cultures * indicates a significant 
difference (P < 0.05). 
Figure 2.4. Oil red o staining of adipose SVF cells and 3T3-L1 cells.  3T3-L1 cells (a, c) shown as positive control. 
Cells received either adipogenic medium for 12 days (c, d) or growth medium supplemented with vehicle for 6 
days (a, b). Following treatment period cells were fixed and stained with oil red o.  Images taken at 10x 
magnification. 
D 
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2.3.4 Effect of removal of non-MSC adipose SVF cells from cell population on 
osteogenic differentiation  
In order to improve differentiation of adipose derived cells, magnetic based 
immunological cell sorting was conducted to increase the proportion of MSCs in vitro by 
removing of CD31 positive endothelial cells, CD54 positive fibroblasts and CD45 
positive hematopoietic cells. During the separation procedure, the total number of cells 
was counted following the removal cells expressing each marker (Figure 2.6). 
Furthermore, cells were also isolated from bone marrow, in order to establish cultures 
with known differentiation capacities.  For both adipose (Figure 2.6 a) and bone marrow 
(Figure 2.6 b) the total number of cells decreased after each incubation event. This 
suggests that the cell cultures subjected to magnetic sorting possessed fewer non-MSC 
SVF cells at the end of the procedure.  
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In order to determine if magnetic sorting affected the osteogenic capacity of 
adipose derived cultures, sorted (n=6) and non-sorted cells (n=9) were cultured in the 
presence of osteogenic media for 21 days (Figure 2.7 e, f). Sorted and non-sorted cultures 
exposed to osteogenic media (figure 2.7 e, f) showed a similar level of alizarin red 
staining to vehicle controls (Figure 2.7 b, c). Additionally, adipose derived cells that 
received osteogenic media displayed much less staining than differentiated Saos-2 cells 
(n=3). In order to compare the level of osteogenic differentiation between groups, the 
amount of alizarin red staining was assessed by eluting the dye retained by each sample. 
The absorbance of the dye elutant was subsequently measured at 550 nm (Figure 2.8 a, 
b). The dye elution data were analysed using the unpaired Student’s T-Test with a one-
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Figure 2.6. Cell yields following serial magnetic separation.  Adipose SVF cells (a) and 
bone marrow SVF cells (b) were counted following the serial removal of CD 31 positive 
cells, CD 54 positive cells, and CD 45 cells. Data points acquired from 3 biological 
replicates. The starting population was diluted to 1x106 cells for each trial. 
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tailed distribution. No difference was observed between non-sorted cultures that received 
differentiation medium and those that received vehicle (p-value 0.4019). Similarly, no 
differences were observed between sorted cultures and corresponding vehicle controls (p-
value 0.0628). A large significant increase in the amount of alizarin red occurred between 
Saos-2 cultures that received treatment and those that did not (p-value > 0.0001). 
Furthermore, no difference was observed between sorted and non-sorted treatment groups 
(p-value 0.2812). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E 
Figure 2.7. Alizarin red staining of adipose SVF cells following magnetic isolation.  Adipose SVF cells were 
subjected to immunological separation (c, f) or excluded from the separation procedure (b, e). Saos-2 cells (a, d) 
shown as positive control. Cells received either osteogenic medium for 21 days (d, e, f) or growth medium 
supplemented with vehicle for 5 days (a, b, c). Following treatment period cells were fixed and stained with 
alizarin red.  Images taken at 10x magnification.  
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In order to determine if magnetic sorting affected the adipogenic capacity of 
adipose derived cultures, sorted (n=6) and non-sorted cells (n=9) were cultured in the 
presence of adipogenic media for 12 days (Figure 2.9). Sorted and non-sorted cultures 
exposed to adipogenic media (Figure 2.9 e, f) displayed small number of positively 
stained adipocytes when compared to vehicle controls (Figure 2.9 b, c). As a positive 
control for adipogenesis, 3T3-L1 pre-adipocytes (n=3) were subjected the same treatment 
and staining procedure as adipose derived cells. Pre-adipocytes that received treatment 
(Figure 2.9 a) showed a robust differentiation response when compared to 3T3-L1 
cultures that received vehicle (Figure 2.9 b). Similar observations were made using phase 
Figure 2.8. Alizarin red stain elution of adipose SVF cells following magnetic isolation (A) and Saos-2 cells 
(B). Absorbance read at 550 nm of alizarin red eluted from adipose SVF and Saos-2 cells cultured in osteogenic 
differentiation media (Diff) or control media (Ctrl). Adipose SVF cells were subjected to magnetic separation 
(no sorting) or excluded from the separation procedure (sorting control). Data points represent measurements 
made in triplicate, +/- standard error. Data points labelled treatment represent samples diluted in CPC at a ratio 
of 1:3, the absorbance values of these samples were then multiplied by a factor of 3.  Saos-2 data point labelled 
treatment represents samples diluted in CPC at a ratio of 1:10, the absorbance values of these samples were then 
multiplied by a factor of 10. Individual cultures are used as replicates, where n=6 for sorted adipose, n=9 for 
non-sorted, and n=3 for Saos-2 cultures * indicates a significant difference (P < 0.05).  
* B 
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contrast microscopy (appendix Figure 1) In order to compare the level of adipogenic 
differentiation between groups, the amount of oil red o staining was assessed by eluting 
the dye retained by each sample. The absorbance of the dye elutant was subsequently 
measured at 540 nm (Figure 2.10). The dye elution data were analysed using the unpaired 
Student’s T-Test with a one-tailed distribution. No difference was observed between non-
sorted cultures that received differentiation medium and those that received vehicle (p-
value 0.1774). Similarly, no differences were observed between sorted cultures and 
corresponding vehicle controls (p-value 0.2267). A large significant increase in the 
amount of oil red o occurred between 3T3-L1 cultures that received treatment and those 
that did not (p-value > 0.0001). Furthermore a small but significant increase was 
observed between sorted and non-sorted treatment groups (p-value 0.032). 
 
 
 
 
 
 
 
 
 
 
 
A B C 
D 
Figure 2.9. Oil red o staining of adipose SVF cells following magnetic isolation.  Adipose SVF cells were 
subjected to magnetic separation (c, f) or excluded from the separation procedure (b, e). 3T3-L1 cells (a, d) 
shown as positive control. Cells received either adipogenic medium for 12 days (d, e, f) or growth medium 
supplemented with vehicle for 6 days (a, b, c). Following treatment period cells were fixed and stained with oil 
red o.  Images taken at 10x magnification. 
E F 
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2.3.5 Effect of removal of non-MSC bone marrow SVF cells from cell population on 
osteogenic differentiation  
 Compared to adipose, bone marrow is a better defined source of mesenchymal 
stem cells. In order to determine if the osteogenic and adipogenic treatments used on 
sorted and non-sorted adipose derived cells could induce a robust differentiation 
response, sorted and non-sorted bone marrow derived cells were subjected to treatments 
conditions identical treatments conditions as adipose derived cultures.  
Sorted (n=9) and non-sorted (n=9) bone marrow cultures exposed to osteogenic 
media (Figure 2.11 e, f) showed a similar level of alizarin red staining to vehicle controls 
(Figure 2.11 b, c). Additionally, bone marrow derived cells that received osteogenic 
Figure 2.10. Oil red o stain elution of adipose SVF cells following magnetic isolation.  Absorbance read at 540 
nm of oil red o eluted from adipose SVF and 3T3-L1 cells cultured in adipogenic differentiation media (Diff) or 
control media (Ctrl). Adipose SVF cells were subjected to magnetic separation (no sorting) or excluded from the 
separation procedure (sorting control). Data points represent measurements made in triplicate, +/- standard error. 
Individual cultures are used as replicates, where n=6 for adipose sorted, n= 8 for adipose non-sorted, and n=3 for 
3T3-L1 cultures * indicates a significant difference (P < 0.05). 
* 
* 
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media displayed much less staining than differentiated Saos-2 cells. In order to compare 
the level of osteogenic differentiation between groups, the amount of alizarin red staining 
was assessed by eluting the dye retained by each sample (Figure 2.12). Moreover, a small 
but significant difference in the amount of alizarin red eluted was observed between non-
sorted cultures that received differentiation medium and those that received vehicle (p-
value 0.0009). Similarly, a small difference was observed between sorted cultures and 
corresponding vehicle controls (p-value 0.0253). Furthermore no difference was observed 
between sorted and non-sorted treatment groups (p-value 0.1654). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 B C 
D E F 
A 
Figure 2.11 Alizarin red staining of bone marrow SVF cells following magnetic isolation.  Bone marrow SVF 
cells were subjected to immunological separation (c, f) or excluded from the separation procedure (b, e). Saos-2 
cells (a, d) shown as positive control. Cells received either osteogenic medium for 21 days (d, e, f) or growth 
medium supplemented with vehicle for 5 days (a, b, c). Following treatment period cells were fixed and stained 
with alizarin red.  Images taken at 10x magnification.  
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Sorted (n=9) and non-sorted (n=9) bone marrow derived cells were cultured in the 
presence of adipogenic media for 12 days (Figure 2.13). As assessed by phase contrast 
microscopy, sorted and non-sorted cultures exposed to adipogenic media (Figure 2.13 e, 
f) displayed no adipocytes as did vehicle controls (Figure 2.13 b, c).  
 
Figure 2.12. Alizarin red stain elution of bone marrow SVF cells following magnetic isolation (A) and Saos-2 
cells (B). Absorbance read at 550 nm of alizarin red eluted from marrow SVF and Saos-2 cells cultured in 
osteogenic differentiation media (Diff) or control media (Ctrl). Adipose SVF cells were subjected to magnetic 
separation (no sorting) or excluded from the separation procedure (sorting control). Data points represent 
measurements made in triplicate, +/- standard error. Data points labelled treatment represent samples diluted in 
CPC at a ratio of 1:3, the absorbance values of these samples were then multiplied by a factor of 3.  Saos-2 data 
point labelled treatment represents samples diluted in CPC at a ratio of 1:10, the absorbance values of these 
samples were then multiplied by a factor of 10. Individual cultures are used as replicates, where n=9 for marrow 
sorted, n= 9 for marrow non-sorted, and n=3 for Saos=2 cultures * indicates a significant difference (P < 0.05).    
* 
* 
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2.4 Discussion: 
 It was anticipated that access to human adipose tissue would be limited. 
Therefore, it was necessary to develop the methodology for isolating and differentiating 
stromal vascular derived MSCs using adipose obtained from rat. MSCs isolated from 
tissue possess the ability to proliferate in vitro (33). A 0.1% collagenase solution was 
Figure 2.13. Phase contrast images of bone marrow SVF cells following magnetic isolation and adipogenic 
treatment.  Adipose SVF cells were subjected to magnetic separation (c, f) or excluded from the separation 
procedure (b, e). 3T3-L1 cells (a, d) shown as positive control. Cells received either adipogenic medium for 12 
days (d, e, f) or growth medium supplemented with vehicle for 6 days (a, b, c).  Images taken at 20x 
magnification.   
A B C 
F E D 
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used to digest adipose and the cells obtained were cultured in DMEM/F-12 medium 
supplemented with 10% FBS. 2-4 days following seeding, it was observed that culture 
plates seeded with adipose SVF cells were ~ 80-90% confluent. The observed growth 
time is similar to the population doubling time of adipose derived SVF cells calculated by 
Tawonsawatruk et al. 2012. The authors isolated rat adipose SVF cells using collagenase 
digestion and calculated that the population doubled within 4.6 days (149). The above 
results demonstrate that the enzymatic digestion procedure used on rat adipose 
successfully isolated proliferative stromal vascular cells. 
 Osteogenic differentiation of MSCs in vitro can be achieved by exposure to 
dexamethasone, ascorbic acid, and β-glycerophosphate. When provided together, these 
compounds activate the expression of genes which induce MSCs to produce a calcified 
extracellular matrix and differentiate into osteoblasts (148). In order to determine if 
adipose derived SVF cultures contained cells with osteogenic capacity, these cells were 
incubated in the presence of dexamethasone, ascorbic acid, and β-glycerophosphate for 
21 days. Comparison of treated cells with differentiated osteosarcoma cells using alizarin 
red staining showed that the isolated rat SVF cells did not produce a calcified matrix, 
suggesting these cells did not undergo osteogenic differentiation. Additionally, separate 
cultures of cells were treated with adipogenic medium. First, SVF cells were cultured in 
the presence of insulin, biotin, IBMX, pantothenate, dexamethasone, and rosiglitazone 
for 3 days in order to induce MSCs to commit to the adipocyte lineage and develop into 
pre-adipocytes. Subsequently, the cells were exposed to the same combination of 
compounds except for rosiglitazone and IBMX for 9 days in order to induce the 
production of lipid droplets within cells and differentiation into multi-ocular adipocytes 
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(150). Following the treatment period, a minute adipogenic response was observed such 
that only a few adipocytes were produced. The osteogenic and adipogenic treatments 
used have been previously demonstrated to induce differentiation of adipose derived 
MSCs (151, 152). Therefore, it is unlikely that a large population of naïve MSCs was 
present in the isolated SVF cell cultures obtained from rat adipose.  
 Considering that MSCs represent a small population of total SVF cells it was 
hypothesized that removal of non-MSC cells would increase the proportion of cells 
capable of differentiation. In order to enrich cultures, SVF cells were incubated with 
antibody-bound magnetic beads in order to remove CD 54 positive fibroblasts, CD 31 
positive endothelial cells, and CD 45 positive cells of hematopoietic origin. These sorted 
cultures were subsequently exposed to osteogenic or adipogenic differentiation medium. 
Alizarin red staining demonstrated osteogenic differentiation did not occur in sorted 
cultures. Similarly, oil red o staining demonstrated that only minimal adipogenesis 
occurred in enriched cultures, suggesting that removal of non-MSC cell types did not 
improve the ability of adipose derived SVF cells to differentiate. A small but significant 
increase in the amount of oil red o retained by sorted cultures treated with adipogenic 
medium compared to non-sorted cultures was observed. However, neither treatment 
group was significantly different from corresponding negative controls, suggesting that 
sorting did not increase the ability of SVF cells to undergo adipogenesis. In order to 
obtain a sufficient number of cells for the magnetic-sorting method, cells were 
subcultured for 10 passages. Investigations into the effect of long-term culture on MSCs 
suggest that differentiation capacity negatively correlates with time in culture. For 
example, Noer et al. 2007 compared the osteogenic capacity of freshly isolated human 
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adipose derived SVF cells to cells of the same origin following 44-48 population 
doublings (153).  Using alizarin red staining, the authors observed that long-term cultures 
possessed reduced osteogenic ability compared to fresh cultures. Similarly, Kretlow et al. 
2008 compared adipogenic ability of freshly isolated murine bone marrow SVF cells to 
cells of the same origin following 6 passages. Using oil red o staining Kretlow et al. 
observed that adipogenic treatments were less effective at inducing differentiation if cells 
were cultured for a greater length of time (154). With this in mind, it is plausible that 
SVF cultures did not experience differentiation do to prolonged time in cultures. 
Furthermore, it was observed that the sorting procedure reduced the number cells 
following sequential incubations with antibody-bound beads. This suggests that non-
MSC cells were removed. It is also plausible that cell death occurred during this 
procedure and therefore enrichment never occurred or was limited. In order to elucidate 
this possibly fluorescent activated cell sorting would be required. However, the arrival of 
human tissue was not under the control of myself. Considering this, the implementation 
of these procedures was anticipated to increase the length of this preliminary study and 
therefore causing a possible conflict with the ability to begin experimentation on human 
samples.  
 Bone marrow stromal cell differentiation has been thoroughly studied since the 
1970’s (155).  Compared to adipose, which was discovered to possess MSCs by Zuk et 
al. in 2001(28), bone marrow is a better characterized source of stem cells. Considering 
that adipose derived MSCs did not display a robust differentiation response using 
standard differentiation procedures, it was desirable to test these same methods on bone 
marrow derived SVF cells. Moreover, similar to adipose, bone marrow contains 
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fibroblasts, endothelial cells and cells hematopoietic origin (156). Therefore, in order to 
determine whether magnetic could increase the proportion of isolated MSCs in vitro, 
sorting was also performed on marrow SVF cells. Following osteogenic treatment, bone 
marrow SVF cells were stained with alizarin red. Spectrophotometric analysis of eluted 
dye revealed a small significant increase in the amount of dye retained by sorted and non-
sorted cultures compared to corresponding controls. Treatment cultures not subjected to 
sorting increased by a magnitude of 0.1136 while sorted treatment cultures increased by 
0.1141. Compared to differentiated osteosarcoma cells which experienced an increase in 
dye retention by 13.28, the increased staining of bone marrow cells is minute and not 
likely indicative of differentiation. Additionally, phase contrast microscopy of sorted and 
non-sorted bone marrow SVF cells treated with adipogenic media revealed that the 
minimal adipogenic response occurred, similar to that of adipose derived cells. Like 
adipose derived SVF cells, marrow cells were cultured for 10 passages. Thus, the most 
plausible reason that these cells did not experience a robust differentiation response is 
prolonged time in culture.  
 In addition to osteogenic and adipogenic differentiation, MSCs are characterized 
by the ability to differentiate along the chondrogenic lineage into cartilage forming 
chondroblasts. Chondrogenic differentiation of cultured stem cells is typically achieved 
by centrifugation of cells into a pellet and subsequent treatment with insulin, transferrin, 
linoleic acid, dexamethasone, and transforming growth factor β. Differentiated 
chondroblasts produce sulfated proteoglycans in the extracellular matrix, which can be 
detected with alcian blue staining (157, 158). It was desirable to develop methods of 
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inducing chondrogenesis using rat derived cells. However, due to the arrival of human 
samples further work on rat samples could not be performed.   
2.5 Conclusions 
 This study demonstrated that the collagenase digestion method used successfully 
isolated proliferative cells from adipose tissue. When treated with differentiation medium 
these did not display robust adipogenic or osteogenic responses. In order to increase the 
number of MSCs in vitro, magnetic sorting was performed to remove non-MSC SVF 
cells. It was observed that sorting had no effect on differentiation. Furthermore, rat bone 
marrow SVF cells were subjected to sorting and subsequent incubation in differentiation 
mediums. Neither sorted nor non-sorted bone marrow cells experienced a strong 
differentiation response. It is plausible that sorting induced cell death cells during 
isolation. Therefore future work should assess this possibility using fluorescent activated 
cell sorting. Furthermore, MSCs in vitro lose differentiation potency with prolonged time 
in vitro. It is likely that this phenomenon effected SVF cells obtained from adipose and 
marrow. Therefore, future work on human adipose will implement an experimental 
design that minimizes the time cells spend in vitro prior to differentiation.  
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Chapter 3: Human Adipose Derived Mesenchymal Stem Cells: 
Collagenase versus Sonication based Isolation 
 
 
 
Objectives: Determine if the sonication based method is capable of isolating 
mesenchymal stem cells from human adipose tissue with an efficiency comparable to the 
collagenase based method. 
 
Hypothesis: The sonication based will allow the isolation of cells capable of in vitro 
differentiation into osteoblasts, adipocytes, and chonrdroblasts.  
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Abstract 
 Adipose derived MSCs possess the ability to differentiate into connective tissues 
as well as the capacity to enhance cartilage and bone regeneration. Yet, for experimental 
and therapeutic purposes, MSCs have been traditionally isolated from adipose using the 
digestive enzyme, collagenase, which cannot enter a patient.  With this issue in mind 
non-enzymatic sonication based method of MSCs isolation was compared to the 
collagenase method. Excised human adipose from three patients was processed using 
either collagenase or sonication methods. Adherent, proliferative stromal cultures were 
obtained from all individuals using collagenase and cultures from 2 patients were 
obtained using sonication. Compared to the collagenase method, sonication yielded fewer 
total cells. However, when provided osteogenic media, alizarin red staining for osteoid 
revealed that sonication derived cultures possessed a higher capacity for bone 
differentiation than those obtained using collagenase. Following adipogenic treatment, oil 
red o staining for lipid accumulation was similar in cultures obtained using either 
isolation method. Moreover, following incubation in the presence of chondrogenic 
medium, ImageJ analysis of alcian blue staining showed that collagenase derived stromal 
cells underwent a small level of chondrogenisis, while cells obtained from sonication did 
not show a greater level of staining compared to negative controls.  These results suggest 
that it is unlikely that sonication yielded multi-potent MSCs from adipose tissue. 
Importantly, sonication yielded cells with high osteogenic capacity and therefore has 
potential to be incorporated in therapies for bone repair. 
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3.1 Introduction: 
Aging in humans is characterized by a functional decline due to histological and 
biochemical changes in tissue and organ systems. These functional declines often 
manifest as pathological conditions associated with the elderly, such as heart failure, 
osteoporosis, and arthritis. Furthermore, almost all tissues show an age-related decline in 
cellular turnover and regeneration in response to injury or stress (159, 160). Stem cells 
are undifferentiated cells which divide into one cell that retains its undifferentiated 
character, and a second cell that can undergo one or more paths of differentiation. Adult 
stem cells are found in the tissues of organs after the organ has matured. Such cells are 
rare and function to replace dead or dysfunctional cells and repair damaged tissues (5). 
Considering the plethora of pathologies that are associated with aging, stem cell biology 
has been intensely researched with the aim of developing therapies capable of reversing 
degenerative conditions. 
Mesenchymal stem cells (MSCs) are a population of adult stems cells found in 
bone marrow, adipose, and other connective tissues which contribute to tissue 
regeneration. MSCs isolated from tissues are isolated as part of a stromal vascular 
fraction (SVF) which consists of other stromal cells such as hematopoietic cells, and 
connective tissue cells such as fibroblasts and endothelial cells (33). Stem cell therapy 
utilizing isolated MSCs derived from aspirated bone marrow has been demonstrated to 
enhance the repair of damaged tissue such as bone, cartilage, and cardiac tissue (9-11) 
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In vitro, MSCs are characterized as tissue culture plastic adherent cells able to 
differentiate into adipocytes, osteoblasts, and chondrocytes (33). Each of these 
differentiation lineages can be achieved by cell culture mediums containing chemical 
cocktails. Osteogenic differentiation of MSCs requires incubation with ascorbic acid, 
glycerophosphate, and dexamethasone resulting in an increase in calcium deposition in 
the extracellular matrix. Chondrogenic differentiation is performed by centrifuging cells 
to form a cell pellet and culturing the cell pellet with transforming growth factor beta, 
dexamethasone, ascorbic acid, and ITS+ (insulin, transferring, selenous acid and linolic 
acid,). The high pressure micro-environment of the pellet is believed to amplify 
differentiation. This results in the production of sulphated proteoglycans and type II 
collagen. Furthermore, adipogenic differentiation of MSCs is achieved by culturing cells 
with medium supplemented with dexamethasone, insulin, isobutyl methyl xanthine, and 
rosiglitazone (148, 161, 157).  
The aspiration of bone marrow for regenerative therapy is a painful process. 
However, adipose deposits are ubiquitous and easily accessible in large quantities via 
liposuction aspiration. Moreover, adipose tissue is routinely extracted from adults 
undergoing liposuction surgery, and is subsequently discarded (14). Taken together, 
adipose tissue is an attractive source of stem cells for the use in regenerative medicine. 
The standard protocol for isolating MSCs uses bacterial derived collagenase to 
breakdown extracellular peptides in tissue (146). The method is not ideal for clinical 
applications because the sample will be contaminated with potentially toxic exogenous 
enzyme that cannot enter a patient. Recently, the company RegenaStem has patented a 
new method for isolating adipose derived stem cells. The method is based on mechanical 
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isolation of the cells using ultrasonic waves emitted from a standard tissue sonicator. 
Thus, a non-enzymatic method of isolating MSCs from adipose offers a potential 
therapeutic alternative to bone marrow based stem cell therapy.  
3.2 Materials and Methods: 
3.2.1 Reagents:  
 3-isobutyl-1-methylxanthine (IBMX), ascorbate-2-phosphate seqimagnesium salt 
hydrate, biotin, β-glycerophosphate disodium salt, bovine serum albumin  (BSA) fraction 
V, cetylpyridium chloride, dexamethasone, d- pantothenate, dimethyl sulfoxide (DMSO), 
fetal bovine serum (FBS), high glucose Dulbecco’s modified eagles media (DMEM) 
powdered media, human recombinant insulin, paraformaldehyde, penicillin/ 
streptomycin, rosiglitazone, and 0.25% trypsin-EDTA were purchased from Sigma 
Aldrich.  
 Calcium chloride, glutamine, HEPES, methyl salicylate, paraplast X-TRA tissue 
embedding medium (paraffin), potassium chloride, potassium diphosphate, monobasic 
potassium phosphate, sodium bicarbonate, sodium chloride, sodium hydroxide and 
dibasic sodium phosphate were purchased from Fischer Scientific. 
 DMEM/ F-12 powdered media with L-glutamine, and Ham’s F-12 powdered 
media with L-glutamine were purchased from Invitrogen. DPX mounting medium and 
formaldehyde were purchased from BDH chemicals. Collagenase type I was purchased 
from Worthington Biochemical. Hydrochloric acid, isopropanol, sodium hydroxide, and 
xylene were purchased from Caledon. Alizarin red, oil red O, and alcian blue 8GX were 
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purchased from Santa Cruz Biotechnology. ITS+ supplement was purchased from 
Cyagen Biosciences. TGFβ1 was purchased from Prospecbio.  
 3T3-L1 cell line was purchased from Eton Biosciences. Saos-2 cell line was a gift 
from the Dr. Ward lab (Brock University, St. Catharines, Ontario, Canada). 
3.2.2 Sample Donors: 
  Excised adipose tissue from three female donors was obtained with approval of 
the Brock University research ethics board and informed consent of all patients. Patient 
information is summarized in Table 3.1. 
Table 3.1: Patient Information 
Donor Gender Age BMI Surgery 
Patient 1 Female 36 yr 24.6 Abdominoplasty 
Patient 2 Female 51 yr 25 Belt Lipectomy 
Patient 3 Female 26 yr - Belt Lipectomy 
 
3.2.3 Cell Isolation: 
 Adipose derived stromal vascular fraction (SVF) cells were isolated from excised 
human adipose tissue and subjected to either collagenase digestion or sonication. 
Collagenase: preformed as in methods 2.2.3. Sonication: adipose tissue sonication was 
performed using the UP400S (400 W, 24 kHz) sonicator and S14 sonotrode (Hielscher 
Ultrasonics) set to 0.4- 0.5 cycle and 50% amplitude. Tissue was placed on the ultrasonic 
probe of the device and exposed to ultrasonic waves for 30 second bursts. Samples were 
then centrifuged at 600 x g for 5 min.  The supernatant containing the oil layer was 
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removed.  Cells were re-suspended in growth media and centrifuged at 600 x g for 5 min.  
The cells were re-suspended in growth media and placed through a Sterileflip 100 m 
filter (Milipore).  The resultant cell suspension was placed in 175 cm2 tissue culture 
treated flasks.  
3.2.4 Cell Culture:  
 Adipose derived stromal vascular fraction cells: cells (passage 0) obtained using 
collagenase or sonication based methods were cultured in growth media at 37˚C, 5% CO2 
and 3% O2 until cultures reached ~70-80% confluence (5-14 days). In order to avoid cell 
loss, media was changed 5-7 days after isolation. Following this period, media was 
changed every 2 days. Passage 0 cells were sub-cultured to passage 1 using 0.25% 
trypsin-EDTA solution and placed on 100 mm tissue culture treated plates (Sarstedt) at a 
density of 5000 cells/cm2 and allowed to reach 70-80% confluence. Passage 2 cells were 
either stored in freezing media consisting of 10% DMEM/F-12, 10% DMSO, and 80% 
FBS and stored in liquid nitrogen or cultured at a density of 10 000 cells/cm2 on 35 mm 
tissue culture treated plates (NEST). Passage 2 cells at 70-80% confluence were 
transferred to a 20% O2 incubator and were treated with differentiation treatments or 
corresponding vehicles. Osteogenic and adipogenic treatments were performed as in 
methods 2.2.3. Osteosarcoma and preadipocytes were cultured as in methods 2.2.3.  
3.2.5 Cell Counting:  
 Cell counts were performed using a haemocytometer. From passage 1 to passage 
2 population doubling time was calculated using the formula: Doubling time = (T) (ln 
2/ln (Nf/Ni), were T= elapsed time between passages, Nf = final cell number, Ni = initial 
cell number.  
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3.2.6 Staining:  
Alizarin red and oil red o staining was performed as in methods 2.2.5. Alcian 
Blue: cell pellets were fixed overnight in 10% neutral buffered formalin. Pellets were 
dehydrated with a series of increasing ethanol for 30min each (30%, 50%, 70%, 80%, 
95%) and placed in 100% ethanol twice for 45 min. Pellets were then cleared with methyl 
salicylate overnight. Pellets were then incubated at 80oC in 50% methyl salicylate, 50% 
molten paraffin for 30min followed by two incubations in molten paraffin at 80oC for 30 
min. The cell pellets were then placed in embedding trays containing molten paraffin, 
allowed to cool and stored at 4oC. Pellets were then cut into 10 micometer thick sections 
using an AO spencer 820 rotary microtome. Sections were then floated on warm water 
covering Starfrost saline coated slides (Sigma Aldrich). Following sectioning, water was 
removed from slides. Sections were deparafinized in xylene for 3 min and subsequently 
rehydrated in decreasing ethanol (100%, 95%, 70%, 50%) for 3min each.  Slides were 
placed in distilled water for 3 min followed 3 min in 0.1M HCl. Slides were then 
incubated in 1% alcian Blue (dissolved in 0.1M HCl) for 10 min. Following staining, 
slides were briefly rinsed in 0.1M HCl and placed under running tap water for 10 min. 
Sections were then dehydrated with a series of increasing ethanol for 3 min each (50%, 
70%, 95% 100%)  and subsequently cleared in xylene for 3 min. Slides were then treated 
with DPX mounting media and cover-slipped (adapted from 158, 163). 
3.2.7 Imaging:  
 Bright field images of cells in culture were captured using the Hund Wilovert S 
inverted microsocope from Fischer Scientific. Bright field images of stained cells and cell 
pellet sections were obtained using the Nikon eclipse 80i microscope.  
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3.2.8 Dye Elution: 
 Dye elution was performed as in methods 2.2.6. 
3.2.9 ImageJ:  
Images of stained sections were taken at 4x magnification using a Nikon eclipse 
80i microscope under constant microscope settings. Images were then analysed using 
ImageJ densitometry and quantified as mean pixel density.  
3.2.10 Statistics: 
Dye elution and ImageJ data were analyzed using the Student’s T-Test with a one 
tailed distribution. Doubling time data were analyzed using the Student’s T-Test with a 
two tailed distribution. Data were analyzed on GraphPad Prisim version 5. α= 0.05 was 
used to determined statistical significance.  In each analysis, technical replicates 
(individual cultures) were treated as biological replicates in order to achieve statistical 
significance.   
3.3 Results: 
 Collagenase and sonication based isolations were conducted on adipose tissue 
obtained from 3 patients. The cell suspension obtained from each isolation procedure was 
placed into one 175 cm2 flask, resulting in a total of 6 flasks. In order to assess the ability 
of each method to isolate tissue culture plastic adherent cells, the number of adherent 
cells was counted once cultures reached ~70-80% confluence. The collagenase method 
yielded cells from each tissue sample. The sonication method yielded cells from adipose 
tissue obtained from patients 2 and 3, but not patient 1. Additionally, the collagenase 
method yielded a higher number of cells in a shorter period of time from each tissue 
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sample compared to the sonication method (Table 2, Figure 1). The above results 
demonstrate that the sonication based method is capable of obtaining adherent cells and 
suggest that compared to the collagenase based method, sonication is less effective at 
isolating adherent cells. 
 A characteristic of MSCs in vitro is self-replication. Thus, it is desirable that the 
sonication based method is capable of isolating cells that replicate at a similar rate as 
those isolated through collagenase digestion. In order to characterize the growth of the 
SVF cells isolated using each method, the duration of time it takes a population of cells to 
double in number was compared between isolation groups (Figure 2). The mean doubling 
time for the collagenase group (n=6 ) was 107.6 +/- 12.6 hrs and 100.1 +/- 22.7 hrs for 
the sonication group (n=4). The doubling time data were analysed using an unpaired 
student’s T-Test with a two-tailed distribution with α= 0.05. No significant difference in 
doubling time was found between groups (p-value: 0.7633), suggesting that cells isolated 
by both methods have similar growth rates. 
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Table 3.2: Yield of adipose derived SVF cells after passage 0. Individual cultures are used as 
replicates, where n=6 for collagenase group and n= 4 for sonication group. 
Patient Isolation Method Culture Time Cell Number 
1 Collagenase 10 days 1500000 
1 Sonication - 0 
2 Collagenase 10 days 2360000 
2 Sonication 14 days 1260000 
3 Collagenase  5 days 4940000 
3 Sonication 10 days 1100000 
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Figure 3.1. Adipose derived SVF cells after 5 days in culture at 4x magnification. Images 
obtained of cells isolated from patient 1, 2, and 3 using collagenase correspond to: a, c, and f, 
respectively. Images obtained of cells isolated from patient 1, 2, and 3 using sonication 
correspond to: b, d, and e, respectively. 
 
   
a b 
c d 
e f 
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Figure 3.2. Comparison of population doubling times of adipose derived SVF cells obtained using 
collagenase and sonication methods. Data points represent a single measurement made from 6 
samples isolated using the collagenase method and 4 samples using the sonication method +/- 
standard error. Samples taken from passage 1 to passage 2.  
 
 In addition to being tissue culture plastic adherent and undergoing self-
replication, adipose derived MSCs are characterized by the ability to differentiate along 
the osteogenic, adipogenic, and chondrogenic lineages. Osteogenesis is characterized by 
the deposition of a calcified extra-cellular matrix which can be detected by staining with 
alizarin red. Similar to MSCs, the Saos-2 osteosarcoma cell line is capable of osteogenic 
differentiation. As positive control for alizarin red staining of calcification, Saos-2 cells 
were cultured for 28 days in osteogenic media or 6 days in growth media supplemented 
with DMSO (negative control media). Following culture, these cells were fixed and 
stained with alizarin red (Figure 3). Images taken of these cells indicate a strong 
differentiation response by Saos-2 cells cultured in osteogenic media (n=3) (Figure 3a) 
compared to those that received control media (n=3) (Figure 3b). The adipose SVF cells 
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obtained by collagenase digestion (n=6) and sonication (n=4) were similarly cultured in 
osteogenic and control media (collagenase n=9, sonication n=6) and subsequently stained 
with alizarin red (Figure 4). Compared to negative controls, cells obtained using the 
collagenase method from patients 2 and 3 underwent osteogenesis (Figure 4 bi-cii). 
However, cells which were cultured in differentiation media obtained from patient 1 
displayed an absence of alizarin red staining, matching the corresponding negative 
control cultures (Figure ai, aii). All samples obtained using sonication stained positive for 
osteogenesis (Figure di-eii).   
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a  b  
Figure 3.3. Saos-2 cells cultured in ostegenic media for 28 days (b) or control media for 6 days 
(a) and stained with alizarin red. Images at 10x magnification. 
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Figure 3.4. Adipose derived SVF cells cultured in ostegenic media for 28 days (aii, bii, cii, dii, e 
ii) or control media for 6 days (ai, bi, ci, di, ei) from patients 1-3 (p1-p3) and stained with alizarin 
red. Images at 10x magnification. Images a, b, and d were obtained from cells isolated using 
collagenase method (Col). Images c and e were obtained from cells isolated using sonication.  
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 In order to compare the level of osteogenic differentiation between groups, the 
amount of alizarin red staining was assessed by eluting the dye retained by each sample. 
The absorbance of the dye elutant was subsequently measured at 550 nm (Figure 6). The 
dye elution data were analysed using the unpaired Student’s T-Test with a one-tailed 
distribution. The collagenase, sonication, and Saos-2 treatment cultures retained 
significantly more dye than corresponding negative control cultures (p-values: 0.0018, 
<0.0001, <0.0001, respectively). Furthermore, cells isolated using sonication retained 
more dye than those isolated using collagenase (p-value: 0.0157). The above results 
demonstrate the sonication based method is capable of isolating cells with the ability to 
undergo osteogenic differentiation and do so to a slightly greater extent than cells isolated 
using collagenase. 
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Figure 3.5. Absorbance read at 550 nm of alizarin red eluted from adipose SVF and Saos-2 cells 
cultured in osteogenic differentiation media (Diff) or control media (Ctrl). SVF cells were 
obtained using collagenase (Col) or sonication (Son) methods from patients 1-3 (P1-P3). Data 
* 
* 
* 
* 
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points represent measurements made in triplicate from duplicate samples, +/- standard error. Col 
and Son data points labelled treatment represent samples diluted in CPC at a ratio of 1:3, the 
absorbance values of these samples were then multiplied by a factor of 3.  Saos-2 data point 
labelled treatment represents samples diluted in CPC at a ratio of 1:10, the absorbance values of 
these samples were then multiplied by a factor of 10. Individual cultures are used as replicates, 
where n=9 for Col treatment, n= 6 for Col control, n=6 for Son control, and n=4 for Son 
treatment cultures. * indicates a significant difference. 
 Adipogenic differentiation is characterized by the formation of spherical 
intracellular lipid droplets which can be detected with oil red O staining. Similar to 
MSCs, 3T3-L1 preadipocytes are capable of adipogenesis. As a positive control for oil 
red of staining of lipids, 3T3-L1 cells (n=3) were cultured in adipogenic media or 
negative control media (growth media supplemented with vehicle controls). Following 
the culture period, 3T3-L1 cells were fixed and stained with oil red O (Figure 7). Images 
taken of these cultures show a strong positive staining for lipids in cultures that received 
adipogenic media (Figure 7b) compared to those that received control media (Figure 7b). 
The adipose SVF cells obtained by collagenase digestion and sonication were similarly 
cultured in adipogenic (n=9 collagenase, n=6 sonication) and control media (n=9 
collagenase, n=6 sonication) and subsequently stained with oil red O (Figure 8). 
Compared to negative controls, cells obtained using either collagenase (Figure 8a, b, and 
d) or sonication (Figure 8 c, e) from each patient displayed adipocytes stained with oil red 
O. However, the differentiation response of the human cells was marginal compared to 
that of the 3T3-L1 cells. 
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Figure 3.6. 3T3-L1 cells cultured in adipogenic media for 12 days (b) or control media for 6 days 
(a) and      stained with oil red O. Images at 10x magnification. 
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Figure 3.7. Adipose derived SVF cells cultured in adipogenic media for 12 days (aii, bii, cii, d ii, eii 
)or control media for 6 days (ai, bi, ci, di, ei) from patients 1-3 (p1-p3) and stained with oil red o. 
Images at 10x magnification. Images a, b, and d were obtained from cells isolated using 
collagenase method (col). Images c, and e were obtained from cells isolated using sonication 
(son).  
 In order to compare the level of adipogenic differentiation between groups, the 
amount of oil red O staining was assessed by eluting the dye retained by each sample. 
The absorbance of the dye elutant was subsequently measured at 540 nm (Figure 9). The 
dye elution data were analysed using the unpaired Student’s T-Test with a one-tailed 
distribution. The collagenase, sonication, and 3T3-L1 treatment cultures retained more 
dye than corresponding negative control cultures, however this difference was marginal 
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(p-values: <0.0001, <0.0003, <0.0001 respectively). Furthermore, the amount of dye 
retained by cells isolated using sonication was not different compared to those isolated 
using collagenase (p-value: 0.8945). Together the images and dye elution show that cells 
isolated using sonication or collagenase experienced low levels of adipogenic 
differentiation. 
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Figure 3.8. Absorbance read at 540 nm of oil red O eluted from adipose SVF cells cultured in 
adipogenic differentiation media (Diff) or control media (Ctrl) obtained using collagenase (Col) 
or sonication (Son) methods from patients 1-3 (P1-P3). Data points represent measurements made 
in triplicate from duplicate samples, +/- standard error. Individual cultures are used as replicates, 
where n=9 for Col treatment, n= 9 for Col control, n=6 for Son control,n=6 for Son treatment, 
and n=3 for 3T3-L1 cultures * indicates a significant difference. 
 Chondrogensis is characterized by the production of sulphated proteoglycans in 
the extra-cellular matrix which can be detected with alician blue staining. Adipose SVF 
cells were pelleted and cultured in chondrogenic media for 28 days or control media for 
24 hrs. Following the culture period, pellets were sectioned, embedded with paraffin, and 
* 
* * 
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stained with alcian blue (Figure 10). Images taken of the sections displayed no distinct 
difference in the levels of staining between collagenase or sonication treatment groups 
and their corresponding control pellets. In order to further analyse the amount of stain on 
the sections, ImageJ software was used to quantify the mean pixel density of sections 
obtained from the pellets (Figure 11). ImageJ data were analyzed using an unpaired 
Student’s T-Test with a one-tailed distribution, α = 0.05. A small, but significant increase 
with detected in staining intensity between treatment (n=5) and control (n=4) samples for 
pellets derived from collagenase isolated cells (p-value:0.01). No difference was detected 
between sonication treatment (n=6) and control (n=2) samples (p-value: 0.1466) or 
between collagenase and sonication treatment groups (p-value: 0.8251). The above 
results suggest that cells isolated using collagenase underwent a low level of 
chondrogenic differentiation, while those isolated using sonication did not undergo 
differentiation. 
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Figure 3.9. Pelleted adipose derived SVF cells cultured in chondrogenic media for 28 days (aii, 
bii, cii, d ii) or control media for 6 days (ai- ei) from patients 2 and 3 (p2, p3). Pelletes were 
embedded in paraffin, cut into 10 µm thick sections, and stained with alcian blue. Images at 4x 
magnification. Images a, and c were obtained from cells isolated using collagenase (col) method. 
Images b, and d were obtained from cells isolated using sonication (son). 
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3.4 Discussion:  
 The current study demonstrated that the sonication based method of cell isolation 
is capable of isolating proliferative, adherent cells with high ostegenic potential, but 
minimal adipogenic potential, and no ability to undergo chondrogenesis. Comparatively, 
cells isolated using collagenase digestion possessed similar differentiation capabilities, 
but were able to undergo a small level of chondrogenesis. Compared to the collagenase 
method, sonication isolated fewer passage 0 cells. Recently, Gimble et. al. developed a 
non-enzymatic method of isolating stem cells from adipose based on shaking lipoaspirate 
in PBS by hand in order to liberate cells (164). The authors observed that compared to 
collagenase isolation, the shaking method produced ~ 25 000 cells/ml tissue after an 
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Figure 3.10. Alcian blue staining intensity of embedded cell pellet sections. Cells were isolated using 
either the collagenase method (col) or sonication (son) method and received chondrogenic media for 28 
days (treatment) or growth media (ctrl) for 24hrs. Cell intensity was determined using ImageJ 
densitometry and quantified as mean pixel density in arbitrary units. Data points represent average 
staining intensity of sections obtained from pellets (col ctrl = 4 pellets, col treatment = 5 pellets, son ctrl 
= 2 pellets, son treatment = 6 pellets). Pellets were derived from cells obtained from 2 biological 
replicates. * indicates a significant difference. 
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average of 13 days culture time. In comparison the sonication based method produced ~ 
42 000 cells/ml tissue from the two successful trials within 10 days. Similar to the 
shaking method, sonication yielded fewer cells than collagenase digestion. However, it is 
likely that the shaking method yielded fewer cells due to insufficient disruption to the 
adipose extra-cellular matrix. Alternatively, it is plausible that due to high energy and 
heat associated with ultrasonic wave emission, low cell yields through sonication may be 
due to excessive cell lysis.  
  Both collagenase and sonication derived cells underwent osteogenic 
differentiation. The level osteogensis as determined by alizarin red stain elution was 
greater in sonication derived cultures than those obtained using collagenase. There is no 
apparent reason why this occurred, the only difference between cultures was number of 
cells in passage 0 cultures. High oxygen levels have been observed to enhance 
osteogenesis of MSCs (165). It is possible that fewer cells in culture may have 
ameliorated media oxygen depletion, pre-disposing these cells along an osteogenic 
lineage.   Nevertheless, these results suggest that the sonication method possesses 
potential to become incorporated into cellular therapies for bone repair. 
 Minimal adipogenesis was observed in sonication and collagenase derived 
cultures. The adipogenic treatment implemented consisted of an initial treatment period 
intended to induce the formation of preadipocytes from MSCs and a second treatment 
period which favors lipogenesis and the development of adipocytes (161). Several other 
adipogenic treatment protocols have been successfully used to induce a robust adipogenic 
response. A key inducer of adipogenesis are PPARγ agonists (107). The current protocol 
utilized rosglitzone, however, alternatives such indomethacin are also potent stimulators 
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of adipogenesis (161, 166, 88). Thus, it is plausible that with altered treatment, the 
isolated cells may have undergone higher levels of adipogenesis.   
 Following sub-culture to passage 2, isolated cells were subsequently 
cryopreserved, further sub-cultured and then provided treatments to induce chondrogenic 
differentiation. ImageJ analysis suggests that cells obtained using sonication were unable 
to differentiate into chondrocytes, while those obtained using collagenase underwent a 
small degree of differentiation. The limited chondrogenic potential of the isolated cells is 
likely due to over cultivation. Evidence suggests that with increased time in culture, the 
ability of MSCs to differentiate diminishes (88). Another possibility is that the 
cryopreservation process affected differentiation potential. However, research by 
Minonzio et. al. suggests that MSCs maintain this ability after the freezing process (167). 
Alternatively, several chondrogenic treatment regimes have been implemented in other 
studies. For example the use of bone morphogenetic proteins (BMP) and other TGFβ 
isoforms are alternatives to TGFβ1 used in this study (157).The results obtained from the 
sectioned pellets are limited due to the small number of technical replicates that were 
available for analysis. Thus, this study was unable to provide definitive evidence of 
chondrogenic differentiation. A higher sample size in addition to addition methods of 
assessing chondrogenesis such quantifying collagen type II and chondroitin-4-sulfate 
production would provide more substantial evidence (157).  
3.5 Conclusions 
 This study was able to demonstrate that the sonication based method of isolating 
adipose derived SVF cells is capable of yielding proliferative, plastic adherent cells with 
osteogenic and adipogenic ability. These results were comparable to those obtained using 
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collagenase digestion, the standard method of adipose MSCs. However, ImageJ 
densitometry analysis of alcian blue stained sections suggests that cells obtained using 
sonication were unable to undergo chondrogenesis. Considering the above, it is unlikely 
that sonication yield multi-potent MSCs from adipose tissue. Yet, the obtained results 
demonstrate that the sonication method possesses potential to become incorporated into 
cellular therapies for bone repair. 
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Chapter 4: Development of a method for the differentiation of  
adipose-derived stem cells into brite cells 
 
Objectives:  Assess the effectiveness of different approaches to induce the differentiation 
of white adipose derived stromal vascular fraction cells into brite cells. 
Hypothesis: Differentiation medium containing stimulators of UCP1 expression will 
induce stromal vascular cells to differentiate into UCP1 expressing cells with high 
mitochondrial content.  
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Abstract 
 Within white adipose tissue (WAT) resides populations of stem cells that can 
differentiate into brite cells. Similar to brown adipose tissue (BAT) cells, brite cells 
possess the ability to activate mitochondrial respiration via uncoupling protein 1 (UCP1)-
mediated uncoupling of oxidative phosphorylation. Stimulators of UCP1 expression such 
as norepinephrine (NE), triiodothyronine (T3), and rosiglitazone have been reported to 
induce the differentiation of WAT stem cells into brite cells in vitro. Considering this, the 
ability of media containing stimulators of UCP1 expression to induce the differentiation 
of WAT stem cells into brite cells was assessed here. Rat subcutaneous WAT stromal cell 
cultures were obtained using methods established in Chapter 2.  These cells received 
either normal growth media or differentiation medium with or without chronic NE 
treatment.  Cells receiving either differentiation medium developed a lipid filled 
morphology and high mitochondrial content as determined by citrate synthase activity. 
Moreover, cells that received differentiation media displayed higher oxygen consumption 
than those that received control media.  However, neither acute NE treatment nor chronic 
NE treatment during differentiation significantly increased cellular respiration. The 
primary characteristic of brite cells is the expression of UCP1, and therefore UCP1 was 
probed in cell lysates using western blotting. BAT homogenates isolated from the 
intrascapular region of rats were used as positive controls for UCP1 detection.  No UCP1 
signal was detected in any lysates from stromal cells. These results suggest that while the 
differentiation medium utilized induced some characteristics of brite cells (lipid storage 
and greater mitochondrial abundance than undifferentiated control cells), differentiation 
was incomplete since UCP1 was absent as was NE-stimulation of respiration.  
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4.1 Introduction 
 Sedentary living and the consumption of calorie-dense food has led to a rise in 
obesity throughout the developed world. This is especially alarming since it is associated 
with the increased occurrence of obesity-associated pathologies such as hyper-tension, 
type 2 diabetes, hyperglycemia, and many types of cancer (135, 136). Obesity-related 
conditions arise due to an imbalance between energy intake and expenditure, resulting in 
excess energy stored as lipid in WAT (168). In addition to WAT, humans and small 
mammals possess stores of BAT within intrascapular regions and peripheral tissues. BAT 
oxidizes fuel depots in order to produce heat. This is achieved by activation of 
uncoupling of oxidative phosphorylation by UCP1.  Because heat is produced during this 
process, it is called non-shivering thermogenesis (112). Furthermore, populations of stem 
cells within WAT are capable of differentiating into UCP1-expressing BAT-like 
adipocytes known as brite cells, which possess similar morphology and function to BAT 
adipocytes (7, 113). Investigations into the relationship between non-shivering 
thermogenesis and lipid metabolism have revealed that enhanced BAT activity is capable 
of conferring anti-obesity properties. For example, UCP1-knockout mice housed under 
thermo-neutral conditions (30oC) gained more weight within adipose depots than wild-
type controls (114) Moreover, Kopecky et al. 1995 constitutively expressed UCP1 in 
WAT depots of genetically obese Avy mice. Compared to non-transgenic mice, UCP1 
expressing mice displayed reductions in total body weight and subcutaneous depots. 
(137). Thus, the induction of brite cell differentiation from WAT derived stem cells is a 
potential therapeutic intervention to ameliorate the symptoms of obesity-associated 
diseases.  In theory, one could harvest these WAT derived stem cells in the aspirate from 
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a liposuction patient, differentiate them into brite cells, and re-introduce them into the 
patient to promote long-term energy homeostasis and ameliorate weight gain. 
 In order to induce the differentiation of WAT derived SVF stem cells into brite 
cells in vitro, specific culture supplements have been utilized. For example, NE, 
rosiglitazone, and T3 activate the UCP1 promoter region, causing increased UCP1 
transcription (7, 112, 113, 118-120,124). WAT SVF cells or brown pre-adipocytes 
cultured in the presence of these inducers differentiate into brite cells and BAT cells, 
respectively.  In addition to specific stimulators of UCP1, IBMX in combination with 
insulin and dexamethasone is commonly utilized to induce brite cell and brown adipocyte 
differentiation. IBMX is hypothesized to indirectly increase UCP1 transcription by 
elevating cAMP levels (115). Insulin and dexamethasone (a synthetic glucocorticoid) are 
also necessary for brite cell differentiation. Little is known concerning the specific 
molecular mechanisms of these molecules in the differentiation process. However, the 
presence of glucocorticoids is postulated to be necessary for the accumulation of lipid 
stores in differentiating brown adipocytes (123). Moreover, the presence of insulin and 
the activation of its downstream effector, IRS, are necessary for brown adipogenesis 
(125).  Considering the above, the effectiveness differentiation medium containing NE, 
T3, indomethacin, rosiglitazone, dexamethasone, IBMX, and insulin to induce a brite cell 
phenotype in WAT SVF cells was assessed. 
4.2 Materials and Methods 
Acetyl CoA, 3-isobutyl-1-methylxanthine (IBMX), bovine serum albumin  (BSA) 
fraction V, dexamethasone, d- pantothenate, dimethyl sulfoxide (DMSO), 5,5’-dithiobis 
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(2-nitrobenzoic acid), dithiolthreitol, fetal bovine serum (FBS), human recombinant 
insulin, norepinephrine, oxaloacetate, paraformaldehyde, penicillin/ streptomycin, 
rosiglitazone, 0.25% trypsin-EDTA, and triiodothyronine were purchased from Sigma 
Aldrich. 
 DMEM/ F-12 powdered media with L-glutamine, and Ham’s F-12 powdered 
media with L-glutamine were purchased from Invitrogen. Collagenase type I was 
purchased from Worthington Biochemical. Hydrochloric acid and sodium hydroxide 
were purchased from Caledon. 
Potassium chloride, potassium diphosphate, monobasic potassium phosphate, 
sodium bicarbonate, sodium chloride, dibasic sodium phosphate, and Tris were purchased 
from Fischer Scientific. Glycerol, NP-40, and triton X-100 were purchased from Bioshop 
Canada. Bradford assay kit was purchased from Biorad. Polyvinylidene difluoride and 
rabbit anti-UCP1 antibody were purchased from Abcam. Rabbit anti-MnSOD antibody 
was purchased from Stressgen. Rabbit anti-actin antibody was purchased from Santa 
Cruz. Anti-rabbit IR800 antibody was purchased from Rockland. 
4.2.1 Animals and primary cell line isolation 
The use of experimental animals was approved by the Brock University ACUC. 
Young adult Long Evans rats were euthanized by decapitation with a guillotine. 
Subcutaneous WAT and intra-scapular BAT were excised and subjected to collagenase 
digestion as per methods 2.2.3. Digested brown adipose tissue was stored at -80oC. 
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4.2.2 Cell Culture:   
Stromal vascular cells obtained from WAT were cultured in growth media at 
37˚C, 5% CO2 and 3% O2. Once passage 0 cultures reached ~70-80% confluence the 
cultures were split at a ratio of 1:2 using 0.25% trypsin-EDTA solution.  Adipose derived 
cells were further subcultured for 1-2 more passages until confluency was reached. 
Subsequently, cells were exposed to trypsin and plated on 35 mm tissue culture treated 
glass bottom dishes at a density of 15 000 cells/cm2. Once reaching confluency cells were 
transferred to a 20% O2 incubator and were treated with differentiation treatments or 
corresponding vehicles.  
Brite Cell Differentiation Treatment: For 48 h cells were cultured in induction media 
consisting of growth media supplemented with 5µg/ml insulin (dissolved in 4mM HCl), 
1nM triiodothyronine dissolved in 1M NaOH, 125uM indomethacin dissolved in ethanol, 
2µg/ml dexamethasone dissolved in ethanol, 0.5mM IBMX dissolved in DMSO, and 
0.5µM rosiglitazone dissolved in DMSO. For an additional 48h, cells received 
maintenance media consisting of growth media supplemented with 5µg/ml insulin, 1nM 
triiodothyronine, and 0.5µM rosiglitazone. Subsequently, cells were then cultured in a 
second maintenance media consisting of 5µg/ml insulin, 1nM triiodothyronine, and 1µM 
rosiglitazone for 5 days. During the final 24h of treatment a separate group of cells also 
received 1µM norepinephrine (NE). Additionally, cultures of control cells received 
equivalent volumes of the vehicle solvents provided to cells receiving differentiation 
medium. For 48h cells received growth media supplemented with 1x10-4 % 4mM HCl, 
1x10-5 % 1M NaOH, 2x10-4 % ethanol, and 2x10-4 % DMSO. For additional 48h, control 
cells received growth media supplemented with 1x10-4 4mM HCl, 1x10-5 % NaOH, and 
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5x10-6 % DMSO. Control cells then received the same supplemented growth medium for 
5 days except with 1x10-5 % DMSO. 
4.2.3 Imaging:  
 Phase contrast images of cells in culture were captured using the Hund Wilovert S 
inverted microsocope from Fischer Scientific. 
4.2.4 Cellular Respiration:   
 Cellular oxygen consumption was measured at 37oC using a Rank Brothers Dual 
digital (model 20) respirometer with a water-jacketed cell chamber. Treated and control 
cells were washed with PBS, harvested from culture plates using trypsin, centrifuged at 
700 x g for 2min, and resuspended in 1ml of DMEM/F-12 without FBS. The cell 
suspension was then added to the respirometry chamber. Respiration rates of cells were 
recorded for approximately 10 min. Respiration rates were determined once a stable 
linear rate was obtained and again following introduction of 1µM NE to respiring cells. 
Subsequently, cell suspensions were collected from the cell chamber, washed with PBS, 
pelleted by centrifugation at 700 x g for 2min and frozen at  -80oC. 
4.2.5 Preparation of lysates from WAT SVF cell and Brown adipose tissue: 
 Lysates were prepared from frozen white adipose-derived cell pellets and digested 
BAT. Cells and tissue digests were resuspended in two volumes of ice cold lysis buffer 
(10mM Tris pH 8.0, 150mM NaCl, 2mM EDTA, 2mM Dithiolthreitol (DTT), 40% 
glycerol, and 0.5% NP40) and incubated for 1hr with periodic sonication (Ultrasonic Inc 
Sonicator W-375). Following incubation, cell lysates were centrifuged at 10 000 x g at 
4oC for 10min (Fisher Scientific accuSpinTM Micro R). Protein concentrations of the cell 
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and tissue lysates were determined by the Bradford method using a BioRad protein assay 
kit. Lysates were stored at -80oC.   
4.2.6 Citrate Synthase Activity: 
 Citrate synthase activity was determined using a Varian Cary 100 Bio UV-Visible 
Spectrophotometer equipped with a Peltier thermostatable cell changer maintained at 
30oC. Citrate synthase was monitored at 412nm. The assay buffer contained 50mM Tris 
pH 8.0, 0.5mM, 5,5’-dithiobis(2-nitrobenzoic acid) (DTNB), 0.1mM Acetyl CoA, 0.05% 
Triton X-100, and 20µg protein. The reaction was initiated by the addition of 0.5mM 
oxaloacetate and absorbance was followed for approximately 2min. 
4.2.7 SDS PAGE and Western Blot: 
 The presence of UCP1 in cell lysates was assessed using western blot analysis. 
MnSOD was used as a proxy of mitochondrial abundance.  Equal amounts (50 ug) of 
whole cell or BAT lysates were subjected to SDS-PAGE on 4% stacking, 12% resolving 
gels and transferred to polyvinylidene difluoride (PVDF) membrane. Membranes were 
visualized using the Odyssey (Li-Cor, Lincoln, NE) detection system. Membranes were 
probed with rabbit anti-MnSOD (1:400 dilution) and rabbit anti-UCP1 (1:250 dilution) 
primary antibodies. Subsequently, membranes were probed with IR 700 conjugate anti-
rabbit secondary (1:2500 dilution).  Images were manipulated and analyzed using 
Odyssey imaging software 1.0. 
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Figure 4.1 Phase contrast images of adipose derived SVF cells following Brite cell differentiation 
treatment with and without chronic NE treatment. Images obtained from at day 0 of treatment (a, b) 
and at day 9 (c,d). Image d is of cells exposed to chronic NE during the final 24h. Images taken at 20x 
magnification. 
4.2.8 Statistical Analysis: 
  Oxygen consumption and citrate synthase activity data were analyzed using the 
Student’s T-Test with a one tailed distribution on GraphPad Prisim version 5. α= 0.05 
was used to determined statistical significance.  
4.3 Results: 
 In order to induce brite cell differentiation in SVF cells, cultures were incubated 
in  differentiation media (see materials and methods 4.3.3) for a period of 9 days. Since 
norepinephrine (NE) is a potent stimulator of UCP1 expression (124) a separate group of 
SVF cells received 1µM NE (chronic treatment) in addition to brite cell differentiation 
media during the final 24h of culture.  Both differentiation regimes promoted the 
development of a phenotype characterized by the accumulation of abundant lipid droplets 
within the cytoplasm. (Figure 4.1). 
     
 
 
 
 
 
 
 
 
 
 
A 
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Figure 4.2 Respiration rates of adipose SVF cells cultured in brite cell differentiation medium before 
and after acute 1µM NE. Data points represent measurements from 2 to 3 technical replicates obtained 
from 5 biological replicates, +/- standard error. N=5 for biological replicates. 
In addition to inducing UCP1 expression, NE also stimulates UCP1 activity and 
therefore increases cellular O2 consumption (7, 113). To determine if the treated cells 
possessed NE-sensitive uncoupling capacity, the rate of oxygen consumption of cells 
(n=5) treated with differentiation media was monitored before and after acute 1µM NE 
treatment (Figure 4.2). No significant difference in oxygen consumption was observed 
after NE treatment (p-value 0.2519; paired T-test). Cultures that received chronic NE 
treatment prior to acute treatment displayed a small but not quite significant increase in 
the rate of O2 compared to cultures that received control media before (p-value 0.0581; 
T-test) and a significant increase after acute NE treatment (p-value 0.0133). However 
acute NE treatment did not stimulate O2 consumption of cells cultured in the presence of 
differentiation media (p-value 0.9321) (Figure 4.3).  
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In addition to possessing thermogenic activity, the brite cell phenotype is 
characterized by increased mitochondrial abundance (124). Furthermore, the activity of 
the mitochondrial matrix enzyme citrate synthase is a strong indicator of mitochondrial 
abundance (169). In order to determine if more mitochondria were present in cells 
cultured in brite cell differentiation medium, the specific activity of citrate synthase was 
spectrophotometrically monitored at 412nm (Figure 4.4).  Cells cultured in the presence 
of differentiation medium (n=5) with and without chronic NE displayed higher citrate 
synthase activity (p-values 0.0105, and >0.0001, respectively) compared to cells cultured 
in control media. Additionally, no difference in citrate synthase activity was observed 
between cells that received chronic NE and those that received differentiation media 
alone (p-value 0.4829). Taken together, the above results suggest that the differentiation 
treatment induced SVF cells to produce more mitochondria, suggesting that a brite cell 
phenotype may be present. 
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Figure 4.4 Citrate synthase activity monitored at 412nm of adipose SVF cells cultured in brite cell differentiation 
medium (diff) in presence or absence of chronic (24hr) 1µM NE or control (ctrl) medium. Data points represent 
measurements from 2 to 3 technical replicates obtained from 5 biological replicates, +/- standard error. * 
indicates a significant difference. 
Figure 4.3 Respiration rates of adipose SVF cells cultured in brite cell differentiation (diff) medium in presence 
or absence of chronic (24hr) NE treatment before and after acute 1µM NE or control (ctrl) medium. Data points 
represent measurements from 2 to 3 technical replicates obtained from 5 biological replicates, +/- standard error. 
* indicates a significant difference. 
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Figure 4.5 Representative western blot for the presence UCP1 and MnSOD in lysates obtained from adipose 
SVF cells cultured in brite cell differentiation medium for 9 days with chronic (24hr) 1µM NE or control 
medium. Lanes 1, 3, and 5 display protein obtained from control cells. Lanes 2, 4, and 6 display protein obtained 
from cells cultured in differentiation medium. Lane 7 displays protein obtained from BAT extract. 
The primary distinguishing characteristic of brite cells is the expression of UCP1. 
Therefore the presence of UCP1 in SVF cells was assessed using western blotting. In 
addition to brite cells, brown adipocytes are only cell type that expresses UCP1. Thus, 
BAT protein extracts were used as a positive control for UCP1 detection. Lysates 
obtained from BAT and cultures exposed to chronic NE treatment (2 biological 
replicates) were probed for UCP1 (Figure 4.5 and Appendix Figure 2). UCP1 was only 
observed in lanes containing BAT lysate. Thus, above evidence suggests that the 
differentiation medium did not induce WAT SVF cells to differentiate into brite cells. 
  
 
 
 
 
 
4.4 Discussion 
Cultures that received either differentiation media or differentiation media plus 
chronic NE developed a lipid filled morphology following 9 days of treatment. This 
characteristic is associated with BAT adipocytes, brite cells, and WAT adipocytes (96, 
112, 113). A possible explanation is that dexamethasone (a synthetic glucocorticoid 
receptor agonist) within the differentiation media induced this morphological change.  Li 
et al. 2006 observed that dexamethasone treatment alone increases the level of lipid 
MnSOD 
UCP1 
Lane 7 Lane 3 Lane 4 Lane 5 Lane 6 Lane 2 Lane 1 
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accumulation within cultured marrow MSCs (170). Prior to lipid accumulation, WAT 
stromal cells displayed a fibroblast-like phenotype, suggesting that the differentiation 
medium induced stromal cells to possess an adipogenic phenotype. 
Compared to undifferentiated stem cells and WAT adipocytes, brite cells and 
brown adipocytes contain high amounts of mitochondria in order to generate heat via 
thermogenesis (112, 113, 171). In order to assess mitochondrial abundance, citrate 
synthase activity was measured. The citrate synthase activity of cells cultured in 
differentiation medium (with and without chronic NE) was higher than that of control 
cultures, indicating an increased mitochondrial content in treated cells. Petrovic et al. 
2010 observed that WAT stromal cells induced to differentiate into brite displayed 
increased expression of PGC1α, a marker of mitochondrial content (124). Considering 
that WAT possesses a low mitochondrial content, the above results suggest that the 
differentiation medium induced the WAT SVF cells to develop more mitochondria and 
produce lipid droplets, features that are consistent with differentiated brite cells.   
Previous investigations have demonstrated that acute NE exposure increases 
respiration in BAT and brite cells by activating UCP1 dependent thermogenesis (7, 113, 
124).  Thus, in order to assess if the differentiation medium induced differentiation of 
WAT SVF cells into brite cells, the rate of oxygen consumption was measured before and 
after acute NE exposure. Cultures which received differentiation medium plus chronic 
NE had a higher rate of respiration compared to negative controls.  Considering that 
mitochondrial content is proportional to the amount of oxidative phosphorylation a cell 
can undergo, this result agrees with the observation that cells which received chronic NE 
also displayed higher citrate synthase activity. Furthermore, cultures that received 
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differentiation medium or differentiation medium plus chronic NE did not display 
increased respiration following acute NE exposure. Considering that UCP1 is required to 
elicit this effect, the above result suggests that the differentiation medium did not induce 
UCP1 expression and therefore brite cell differentiation. A possible reason that acute NE 
had no effect is that treated cells did not express β3-adernonergic receptors required to 
activate UCP1. In addition to NE, fatty acids such as oleic and linoleic acids directly 
activate UCP1 (171). Considering this, it would be worthwhile to evaluate O2 
consumption of treated cells in the presence of fatty acids instead of NE.   
 In order to determine if the differentiation medium induced UCP1 expression, cell 
lysates were probed for the presence of UCP1 using western blotting. Positive UCP1 
bands were only detected in BAT extracts run alongside cell lysates obtained from 
cultures exposed to chronic NE, therefore results obtained from cells treated with 
differentiation medium alone are not reliable. Although UCP1 was detected in BAT, no 
corresponding UCP1 expression was observed in cells that received differentiation 
medium plus chronic NE. Taken together, the above results suggest that the 
differentiation medium induced WAT SVF cells to develop intracellular lipids and 
increased mitochondrial content. Yet, NE induced thermogenesis and UCP1 expression 
were absent in these cells. Thus, it seems that there may have been partial differentiation 
and a brite cell type was not fully achieved. The brite differentiation medium and 
treatment regime utilized was based the protocol published by Aune et al. 2013 (119). 
However, little consistency is present in regards to a unified method of differentiating 
WAT SVF cells to brite cells. For example, the number of differentiation inducers 
included and concentrations of constituents within differentiation mediums varies greatly 
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between research groups (117-120,124). Additionally, treatment of WAT stromal cells 
with rosiglitazone or T3 alone has been shown to induce brite cell differentiation (117). 
Moreover, stromal cells were obtained from subcutaneous WAT depots as in Aune et al. 
However, brite cell differentiation has also been achieved in stromal cells obtained from 
WAT surrounding the epididymis (124). Thus, it is possible that varying the levels of the 
compounds used within the differentiation medium or treating epididymally derived 
WAT stromal cells may have resulted in UCP1 expressing brite cells.   
4.5 Conclusions 
 This set of experiments showed that the brite cell differentiation method utilized 
was capable of producing cells with high mitochondrial content and abundant stored lipid 
droplets. However, the medium did not induce UCP1 expression or a capacity for NE-
stimulated respiration. Future efforts to differentiate WAT stromal cells into brite cells 
should assess differentiation medium containing fewer constituents such as using T3 or 
rosiglitazone alone, and utilizing epididymal WAT stromal cells instead of subcutaneous 
WAT cells. 
Chapter 5: General Discussion 
5.1:  MSCs isolated using sonication 
 Methods for obtaining MSCs from adipose have traditionally used collagenase to 
isolate stromal cells from the surrounding extracellular matrix. However, this method is 
not ideal for clinical applications because the sample will be contaminated with 
potentially toxic exogenous enzyme that cannot enter a patient. Here it was shown that 
adipose-derived stromal cells can be isolated using ultrasonic waves emitted from a tissue 
sonicator, eliminating the need for enzyme. In order to be applicable to regenerative 
98 
 
therapies for age-associated diseases, the sonication method must be capable of yielding 
enough cells to administer into a patient and yield cells possessing the ability to 
differentiate into specialized cell types. Investigations using MSCs for the regeneration of 
bone defects have utilized 2.5x105 – 7.5x106 cells (128-131) and 10x106 – 40x106 cells 
for cartilage defects (132, 133), depending on the size of the defect and model organism. 
Following the first passage in vitro, an average of 1.18x106 stromal cells were isolated 
from adipose of 2 patients using the sonication method. In comparison the, collagenase 
method yielded 2.93x106 cells. It is plausible that sonication yielded less cells because the 
high levels of heat associated with sonication caused cell death. Thus, a potential means 
to increase cell yields using sonication would be to lower the ultrasonic exposure time 
and/or decrease ultrasonic wave intensity. Nevertheless, in order to obtain enough 
adipose-derived MSCs for tissue regeneration, the Regenastem sonication method will 
likely require additional in vitro passage steps to increase the total number of cells 
obtained.  
In addition to cell yield, stromal cells must possess the ability to differentiate in 
order to facilitate tissue regeneration. Adipose stromal cells isolated using sonication 
displayed a robust ability to undergo osteogenic differentiation, but not chondrogenic 
differentiation. The osteogenic capability of these cells gives the sonication method 
potential for orthopedic applications. However, the inability to undergo chondrogenisis 
limits the usefulness of the cells isolated with sonication to repair cartilaginous tissue. 
Moreover, this limited differentiation potential raises the question if the sonication 
method yielded any MSCs. Stromal cells isolated using collagenase did show limited 
chondrogenic potential in addition to limited adipogenic and osteogenic potential, 
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suggesting that MSCs were present in the intact adipose. Considering this, it is plausible 
that more alternate chondrogenic differentiation methods may have induced a response in 
the cells obtained using sonication. For example, culturing MSCs compressed within 
polymer beads has been demonstrated to enhance chondrogenic differentiation (10). 
Moreover, inter-donor variability in MSC sensitivity to specific differentiation inducers 
has been reported (10). Thus, using alternate inducers such as other TGFβ isoforms and 
BMPs may elicit a chondrogenic response from stromal cells isolated using sonication.  
5.2: Adipose Stromal Heterogeneity 
 The stroma of adipose contains multiple cell types in addition to MSCs (33). 
Thus, when adipose MSCs are isolated for therapeutic applications, a heterogeneous 
population of cells will be obtained. Because MSCs represent a small fraction of total 
stromal cells, adipose stromal suspensions diluted with non-MSC cell types may possess 
limited potency of a MSC based therapy. Here, adipose and marrow derived stromal cells 
were incubated with anti-CD 54, 31, and, 45 antibody conjugated beads to facilitate the 
removal of fibroblasts, endothelial cells, and immune cells, respectively. It was 
demonstrated that this enrichment procedure had no effect on the differentiation capacity 
of stromal cells. These results suggest that purification prior to introducing MSCs into a 
patient may not be necessary. This concept is supported by in vivo studies that have 
demonstrated tissue regeneration using non-purified stromal cell suspensions (128, 131). 
Moreover, it is possible that non-MSC cell types may aide in the MSC differentiation 
process, and therefore should remain in stem cell suspensions. This hypothesis is 
supported by studies using MSC co-culture systems. For example Kaigler et al. 2005 
cultured endothelial cells with marrow MSCs (173). The in vitro study showed that the 
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osteogenic ability of MSCs increased when in direct contact with endothelial cells. In 
vivo, the authors showed that when endothelial cells combined with MSCs increased 
bone formation compared to fibroblast and MSCs. Similar results have been observed 
autologous derived MSCs in rats and goats (174, 175).   Moreover, in order to obtain 
sufficient numbers of cells to implement magnetic sorting cells were stromal cells were 
expanded for 10 passages. Other groups have observed that in vitro expansion limits 
adipogenic and osteogenic differentiation potential (153, 154).  Thus it is plausible that 
prior to the enrichment procedure, the differentiation potential of stromal cells was 
diminished. With this in mind, non-enzymatic isolation methods (e.g. sonication) and 
enrichment procedures should limit in vitro passaging prior to utilizing MSCs for 
regenerative applications.  
5.3: Brite cell differentiation 
 The biomedical interest in brite and brown adipocytes has focused on the capacity 
of these cell types to counteract diseases such as obesity and diabetes. Such interest stems 
from studies demonstrating that increased activity of brite and brown adipocytes is linked 
to obesity resistance in mouse models (12, 13). Recruitable populations of brite cells 
reside within WAT depots and are believed to originate from resident MSCs (7, 113). 
Thus an important step in utilising brite cells to combat obesity in humans is the 
development of in vitro models of brite cell differentiation. Here, adipose stromal cells 
were incubated with known stimulators of UCP1 expression and brown adipocyte 
differentiation in order to induce brite cell differentiation. Following treatment, cultures 
displayed characteristics of the brite cell phenotype such as increased mitochondrial 
content and lipid accumulation. However, the treated cells were not capable of NE 
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induced thermogenesis or UCP1 expression. Thus, the differentiation protocol utilized 
was unable to induce brite cell differentiation. In order to achieve this, potential 
adjustments to the differentiation method can be implemented. The treatment regime (see 
chapter 4, page 98) relies on the initial induction of stromal cells along the adipogenic 
lineage (119). Subsequent to this, cells received different cocktails to induce a brite cell 
phenotype. Thus it is plausible that extending induction or differentiation treatment 
phases may produce brite cells. Moreover, several groups have utilized the same inducers 
as used here (117-121), but at different concentrations. It would be worthwhile to 
determine if altering the concentrations of media constituents would result in 
differentiation.  
6: Conclusions 
 Adipose derived MSCs possess the ability to differentiate into specialized cell 
types capable of ameliorating symptoms of several age-associated diseases. Moreover, 
adipose is an ideal source of stem cells due to its abundance and accessibility. Thus 
developing novel methods of isolating and differentiating adipose-derived MSCs is an 
important step in creating efficient and minimally invasive regenerative therapies. During 
any isolation procedure for obtaining adipose MSCs, a heterogeneous population of 
adipose stromal cells will be obtained. The use of cell populations in which MSCs are 
significantly diluted by non-MSC stromal cells may limit the capacity of MSCs to 
differentiate in vitro and potentially their ability to facilitate tissue repair. Considering 
this, a magnetic-bead based method of enriching adipose stromal cell cultures was 
assessed. Cells were incubated with magnetic beads targeted at fibroblasts, endothelial 
cells, and immune cells. No significant differences were observed in the ability of 
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enriched cultures to differentiate compared to cultures that were subjected to enrichment. 
This observation suggests that the removal of non-MSC stromal cells may not impact the 
ability of MSCs to differentiate. However, it is likely that prolonged time in culture 
affected the ability of these cells to differentiate. Thus, future efforts to enrich adipose 
stromal cultures should minimize pre-enrichment culture time.  
In order to eliminate the need for digestive enzyme in obtaining adipose MSCs, a 
sonication based method of MSC isolation was assessed. The sonication based method of 
isolating adipose stromal cells was capable of yielding proliferative, plastic adherent cells 
with osteogenic and adipogenic ability. However, cells isolated using sonication were not 
unable to differentiate into chondrocytes. Considering the above, it is unlikely that 
sonication yielded multi-potent MSCs from adipose tissue. However, it is plausible that a 
medium containing alternate stimulators of chondrogenisis may have induced 
differentiation. Considering this, future work assessing the sonication method should 
implement growth factors such as BMPs or other TGFβ isoforms within chondrogenic 
medium.  
Lastly, an in vitro method of inducing adipose derived stromal cells to 
differentiate into brite cells was assessed. The brite cell differentiation medium utilized 
was capable of causing cells to have a high mitochondrial content and the produce of 
lipid droplets. Yet, the medium did not induce the differentiation of WAT SVF cells into 
UCP1 expressing cells capable of NE induced non-shivering thermogenesis. Therefore, 
the differentiation method did not induce SVF cells to become brite cells. The treatment 
regime used known inducers of UCP1 expression and brown adipocyte differentiation. 
Future efforts based on this treatment regime may assess whether extending treatment 
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induction/differentiation periods with these inducers or altering the concentrations of 
inducers is capable of producing brite cells. 
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Appendix Figure 2. Representative western blot for the presence of UCP1, MnSOD, and actin in lysates obtained 
from adipose SVF cells cultured in brite cell differentiation medium for 9 days with chronic (24hr) 1µM NE or 
control medium. Lanes 1, 2, and 3 display protein obtained from cells cultured in differentiation. Lane 4 display 
protein obtained from cells cultured in control medium. Lane 5 displays protein obtained from BAT extract. 
7. Appendix: 
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Appendix Figure 1. Phase contrast images of adipose SVF cells following magnetic isolation and adipogenic 
treatment.  Adipose SVF cells were subjected to magnetic separation (c, f) or excluded from the separation 
procedure (b, e). 3T3-L1 cells (a, d) shown as positive control. Cells received either adipogenic medium for 12 
days (d, e, f) or growth medium supplemented with vehicle for 6 days (a, b, c).  Images taken at 20x 
magnification.   
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